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Bacillus subtilis has long been a model bacterium for understanding biological 
mechanisms, such as fatty acid catabolism and polyketide biosynthesis. Our interest in 
the latter was centered on the polyketide synthase (PKS) mechanism responsible for β-
branching polyketides.  The unique structural moiety is attributed to a HMG-CoA 
synthase homolog, such as the pksG gene in B. subtilis.    
The first goal was a metagenomic survey of local soils, using the conserved pksG 
homolog sequence as a genetic marker.  After optimizing techniques for the extraction 
and purification of environmental DNA, the β-branching polyketide population was not 
detected in any local soil samples.  While working with a pksG homolog, an apparent 
sequence anomaly prompted us to verify the taxonomic classification of B. subtilis 
research strains ATCC 39374 and 39320.  Comparison of DNA sequences (pksG 
homologs, hypervariable regions of 16S rRNA and rDNA) and species-specific genes 
showed the two ATCC strains are more closely related to B. amyloliquefaciens.  
A group of genes named the mmg operon, able to catalyze fatty acid catabolism, 
are active only during B. subtilis sporulation.  Our hypothesis was that, by creating a 
conditional genetic knockout mutation, the bacterium would be capable of in-vitro 
growth in propionate media.  Attempts to subclone portions of mmg DNA were 
unsuccessful.  However, the neighboring YqiQ protein was successfully isolated and 
purified.
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INTRODUCTION TO POLYKETIDE BIOSYNTHESIS 
 
 
I.A. Polyketides 
 As one of the most common classes of natural products, polyketides are made by 
nearly all types of organisms.  Produced by bacteria and fungi alike, they are a 
structurally diverse family of natural products known.  The bioactivity shown by many of 
these secondary metabolites has made them the focus of much scientific inquiry; 
pharmacological applications range from antibiotic, antiparasite, antitumor, 
immunosuppressive, and other chemotherapeutic effects.1  Four examples of these 
naturally occurring polyketides are shown below in Figure 1.1. 
First is rapamycin, an immunosuppressant compound that halts tumor growth by 
cell-cycle inhibition; this antibiotic is administered to patients receiving organ 
transplants.2, 3  Next is soraphen, a fungal, acetyl CoA carboxylase inhibitor that is used 
as a crop protectant for its ability to control plant pathogens. 4  From Streptomyces 
glaucescens, the decaketide tetracenomycin C antibiotic is a cytotoxic antibiotic. 5  It has 
broad activity against the actinomycete molecular class.  Erythromycin A is a broad-
spectrum antibiotic that exhibits therapeutic effects against Gram-positive bacteria via a 
ribosome growth inhibition mechanism.6  Initially isolated in 1952 from 
Saccharopolyspora erythraea, it has since become the model for both polyketide 
antibiotics and their biosynthesis.6
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Figure 1.1.  Polyketide natural products. 3-6 
 
 
Structural diversity among polyketides is elucidated by understanding their 
biosyntheses.  Assembly occurs within polyketide synthases (PKS)– large groupings of 
multifunctional enzymes, similar to peptide-forming nonribosomal peptide synthetase 
(NRPS) systems and fatty acid synthases (FAS).7   
There are three PKS classifications, denoted Type I, II, and III; each has different 
enzyme arrangements and overall mechanisms.8  Type I synthases contain multiple 
modular arrangements of specific enzyme domains, and use each module once for the 
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production of a single β-keto acyl moiety.8  Two subclasses exist within Type I PKSs: for 
bacteria the above system prevails, while iterative fungi use modules more than once for 
biosynthetic processes.1 
 Three enzyme domains are required for the “minimal” Type I PKS module; these 
are ketoacyl synthase (KS), acyl transferase (AT), and an acyl carrier protein (ACP) that 
contains at least one thiolation domain.9  Polyketide chains are elongated by an acyl 
addition that is catalyzed by these groups.  Three additional common domains that may 
be present for reduction of the chain are ketoreductase (KR), dehydratase (DH), and 
enoyl reductase (ER).  Lastly, thioesterase (TE) catalyzes either hydrolysis or 
macrolactonization to release the polyketide product from the acyl carrier protein (ACP) 
that binds it to a PKS.8     
 Type II PKSs contain synthases arranged among different polypeptides and are 
known for producing compounds such as tetracenomycin C and aromatic polyketides.  
This arrangement is similar to fungal synthases, with each synthase used repeatedly 
during chain elongation.1  The Type III composition contains single multifunctional 
modules that are used once, yet these PKSs lack the 4’-phosphopantetheine moeity.8   
The terminal sulfhydryl group of this structure is responsible for essential Coenzyme A 
utilization in polyketide biosynthesis; it is also responsible for modifying synthase ACPs 
and enabling them to process growing polyketide chains.7, 10 
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I.B. Polyketide Biosynthesis 
I.B.1. Erythromycin 
 Discovered in soil samples in the Philippines, Erythromycin A (EryA) was first 
isolated from the Gram-positive bacteria S. eythraea; EryA and its derivatives have 
shown neurotrophic, immunosuppressant, antineoplastic, antiparasitic, and anti-
inflammatory bioactivity, along with other therapeutic applications.11, 12  Its biosynthetic 
mechanism has become a model for other polyketides for many reasons; one is its 
utilization of the large, multifunctional 6-deoxyerythronolide B synthase (DEBS) system, 
and another is the possibility of novel drug design by structural modification.  DEBS 
contains three large proteins, each with multiple enzymatic modules.13  Stereospecific 
representations of erythromycin A and its precursor, 6-deoxyerythronolide B (6-dEB), are 
shown in Figure 1.2. 
 
 
Figure 1.2. 6-dEB precursor and erythromycin A.12 
 
 
 As with the majority of Type I PKS gene clusters, a propionyl-CoA starter unit is 
first loaded onto an acyl carrier protein.  Condensation reactions then occur consecutively 
with six [S]-methylmalonyl-CoA derivatives, one per module.  Each resulting β-ketoester 
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group may then be reduced by an enzyme of the PKS; modular organization dictates the 
resulting polyketide chain structure.  The initial 6-dEB macrolide ring is formed via the 
PKS machinery, after which one P450 enzyme hydroxylates the precursor, and two 
deoxysugars are attached.  Two reactions are needed to complete erythromycin A 
biosynthesis, and may occur in any order.  These are an EryG-catalyzed methylation step 
and hydroxylation by EryK, a second P450 molecule.12   
 Propionyl-CoA is typically made available by either carbohydrate or fatty acid 
catabolism through the tricarboxylic acid cycle; while the loading module also recognizes 
acetyl-CoA, it is not the preferred substrate for erythromycin biosynthesis.12, 14 The 
modules that make up the three erythromycin DEBS proteins (Figure 1.3) catalyze 
polyketide chain growth and perform cyclization of the end product. 
Macrolide biosynthesis: Once the propionyl group is bound to the acyl carrier 
protein “loading” module, the first [S]-methylmalonyl-CoA is attached to a second ACP 
in module 1 by acyl transferase (AT).  The malonyl group is decarboxylated and 
participates in a Claisen condensation reaction with the propionyl-ACP, catalyzed by β-
ketosynthase (KS).12  This results in a β-ketone group, which is then reduced to an 
alcohol by ketoreductase (KR) in an NADPH-dependent reaction.  Modules two and 
three repeat the chain elongation with two new malonyl derivatives.  In module four the 
β-carbon is reduced further – a dehydratase (DH) eliminates the alcohol to produce an 
unsaturated alkene, and, in another NADPH-dependant reaction, enoyl reductase (ER) 
catalyzes the complete reduction to a fully saturated carbon.  Modules 5 and 6 repeat the 
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chemistry of the 2nd module.  6-dEB biosynthesis is completed by thioesterase (TE) 
catalysis of ring cyclization and release from the acyl carrier protein.12 
 
Figure 1.3. Modular biosynthesis of  6-dEB.14  This is the polyketide precursor to erythromycin. 
 
 
 Erythromycin biosynthesis: The completed synthesis of erythromycin A 
requires addition of the deoxysugars D-desosamine and L-mycarose.  This occurs by one 
of two possible mechanisms, both of which result in the production of erythromycin 
antibiotics EryB, EryC, and EryD.12  The synthetic scheme are shown in Figure 1.4. 
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Figure 1.4. Biosynthesis of  erythromycin antibiotics.11, 12 
 
 
 First, 6-dEB is hydroxylated to erythronolide B by the cytochrome P450 homolog 
eryF, a stereospecific monooxygenase system.11  The two sugars are then added to this 
lactone; synthesis and addition of these is believed to be the rate-limiting step in 
erythromycin production.12  EryBV, a glycosyltransferase encoded by the eryB gene, first 
catalyzes addition of L-mycarose at C-3 to form 3α-mycarosylerythronolide B; EryC 
desosaminyltransferase further glycosylates at C-5 by addition of D-desosamine to 
produce erythromycin D.13  At this stage of the synthesis, there are two possible scenarios 
for the structural modification of erythromycin D to erythromycin A. 
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 Erythromycins B and C are produced by one of two pathways.  The two genes 
involved are eryG and eryK; these encode for an O-methyltransferase enzyme and a 
cytochrome P450 homolog, respectively.  Methylation by eryG at C-3 of the mycarose 
sugar results in erythromycin B, while eryK hydroxylation of this carbon gives 
erythromycin C.13  Depending on the order in which these reactions occur, erythromycin 
A biosynthesis is next completed when either the erythromycin B lactone is hydroxylated 
or erythromycin C is methylated.  While both processes occur, the latter pathway is 
prevalent; with erythromycin B as its substrate, the catalytic activity of the eryK P450 
enzyme is 1200-1900 times higher.13 
 This type of polyketide construction has been discovered across multiple species, 
including Streptomycetes, Nocardioforms, Myxobacteria, Pseudomonadaceae, and other 
bacteria.15  In addition to a PKS gene cluster, some organisms also contain non-ribosomal 
peptide synthase (NRPS) modules; the combination of these two allows for the 
incorporation of amino acids into an elongating  polyketide chain.16, 17  Following 
modular biosynthesis, additional modification to structures may also occur, as with the 
erythromycin deoxysugars. 
 Analysis of the specific mechanisms of erythromycin biosynthesis has led to an 
understanding of many polyketide production systems; it is widely applicable, as many 
Type I PKS gene clusters show homologous processes.  In certain cases where natural 
polyketide products exhibit structural anomalies, there are additional mechanistic 
explanations to be discovered. 
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I.C. β-Branching Polyketides 
 One structural moiety found in naturally occurring molecules that is not explained 
by the conventional understanding of polyketide biosynthesis is the β-branch.  A growing 
polyketide chain is elongated two carbons at a time by addition of malonyl derivatives.  
PKS enzymatic domain arrangement dictates one of four possible functional groups at the 
β-carbon. Table 1 shows the structures normally seen at the keto position of a polyketide, 
and the modular assembly responsible for each; none of these encode for the β-methyl 
group. 
 
MALONYL DERIVATIVE      
ΒETA FUNCTIONAL 
GROUP 
KS, ACP, AT 
O
 
KS, ACP, AT, KR 
OH
 
KS, ACP, AT, DH, KR  
KS, ACP, AT, KR, DH, ER  
???  
α 
β 
R
S
O
ACP
Table 1. Functional groups expected from PKS modular domains. 
 
 
The β-branch is found in several known polyketides, including the Jamaicamides 
and curacin A of marine cyanobacteria, the antibiotics TA and mupirocin of 
Pseudomonas fluorescens, which inhibits bacterial cell wall synthesis, all shown in 
Figure 1.5.18-22  The keto position of the initial malonyl derivative unit is designated by a 
black dot, and each β-branch highlighted by a dashed line. 
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Figure 1.5. Examples of β-branch containing polyketides.18-22 
 
 
 Shown first in Figure 1.5 is the general structure of the jamaicamides, isolated 
from the marine bacterium Lyngbya majuscula by the William H. Gerwick research 
group in 2004.19  They exhibit sodium channel-blocking activity and cytotoxicity towards 
both human and mouse cell cancer lines, an example of the pharmacological applications 
of novel polyketide discovery.19  Mupirocin has bioactivity towards Gram-positive 
bacteria and is one of the few antibiotics in use for treatment of methicillin-resistant 
Staphylococcus aureus.22 
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 Curacin A, found in the marine cyanobacteria in Curacao, is an antitubulin 
compound with cancer cell toxicity that affects cell microtubules at the colchicine drug 
binding site.18  Its biosynthesis utilizes both the PKS and NRPS gene clusters described 
above, as does the last compound in Figure 1.5.  Myxovirescin, or antibiotic TA, is 
produced by the myxobacterium Myxococcus xanthus when it is under stress from 
nutrient shortages; one of its polyketide synthases shows strong sequence homology with 
those of erythromycin and soraphen A.15 
 All sources of the β-branch structural moiety share the presence of large, type I 
PKS gene clusters.  Each of these groups contains similar conserved regions, including a 
freestanding thiolation domain or ACP, and a 3-hydroxy-3-methylglutaryl (HMG)-CoA 
synthase.  Many of the enzyme-encoding ORFs are homologous, even among seemingly 
unrelated species.  These clusters are unique in that they do not follow the colinearity rule 
typical of PKS organization.7, 17  Many also lack acyltransferase (AT) domains within the 
PKS condensation module; instead a single, separate protein acts as a trans-AT to 
facilitate the loading of monomers onto the synthase ACPs.22  This class of synthases are 
thus called “AT-less” PKSs.23 
I.D. Difficidin  
 Four of the Bacillus subtilis antibiotics that contain the β-branch structural moiety 
are difficidin, oxydifficidin, bacillaene, and dihydrobacillaene.23-25  Difficidin and 
oxydifficidin are broad-spectrum antibiotics that were first isolated in 1987 from ATCC 
strains 39274 and 39320 of B. subtilis, the most commonly studied Gram-positive 
bacterium.26-28  It was assumed for ten years that the biosynthesis of difficidin, shown in 
11 
 
Figure 1.6, arose from a large PKS cluster named pksX that was discovered upon 
sequencing of B. subtilis and is represented in Figure 1.7.16, 29-31   
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Figure 1.6. Difficidin and oxydifficidin both contain a β-branch on C-3.32 
 
 
A C SpksN pksRpksMpksJ pksL
I 
H F 
acpK 
G 
E 
B D 
 
 
Figure 1.7. The pksX operon of Bacillus subtilis.23 
 
 
 In 1997, B. subtilis 168 was one of the first organisms to be fully sequenced, and 
while it contained pksX, the strain is incapable of producing difficidin.  An sfp gene that 
encodes for 4’-phosphopantetheine transfer to PKS ACPs is essential for CoA utilization 
in polyketide synthases, and thus for enzymatic production of the polyketide antibiotic.  
However, the gene is silenced in B. subtilis 168 (sfpº), and so the two “wild-type” strains, 
39374 and 39320, have been considered the models for this bacterium’s polyketide 
production.33-36 
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I.E. Bacillaene 
I.E.1. β-branch Biosynthesis 
The 16 pks genes were discovered in 1995 and make up ~2% of the B. subtilis 
genome.17, 23  Bacillaene was first isolated from B. subtilis in 1995, but not structurally 
defined until 2007 when it was discovered to be the product of the pksX gene cluster.7, 24  
In 2006, it was revealed that a related species, Bacillus amyloliquefaciens FZB 42, also 
contained three polyketide synthase clusters which produced bacillaene, macrolactin, and 
difficidin/oxydifficidin,.7  These PKSs are referred to as pks1(bae), pks2 (macrolactin 
biosynthesis), and pks3(dif), respectively, and all are “AT-less” type I synthases.7   
Chen et al. defined the organization of all three and showed the bae gene cluster 
to be a pksX ortholog.7  Both are large PKS/NRPS hybrid complexes, uncommon but 
highly conserved among multiple Bacillus species.7, 8, 17, 24, 25   Bacillaene is an unstable 
compound, and while further characterization has proven difficult, the amount of space 
dedicated to this polyketide machinery indicates possibly important biological 
functions.17   
Characterization of bae’s ortholog, the conserved pksX gene cluster, has made 
clear the manner of β-methyl inclusion in polyketides.7, 23, 30, 37  Each ORF within the 
pksX cluster is homologous to enzymes utilized by Type I PKSs (Table 2.)23  The proteins 
AcpK, PksC, and PksF-I, along with the tandem thiolation domains of PksL, make up a 
“gene cassette” that is now noted in all PKS or PKS/NRPS hybrid systems that synthesize 
a β-branched product.7, 24, 30  Once the functions of these genes were known, the specific 
reactions responsible for incorporating the methyl unit was clear.23   
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Gene Name Gene Function Based on Homology 
pksA Transcriptional regulator 
pksB Zinc-dependant hydrolase 
pksC-D AT (acyl transferases) 
pksE AT with flavin mononucleotide-dependant oxidase 
acpK ACP transferase 
pksF Ketosynthase 
pksG Hydroxymethylglutaryl (HMG)-CoA synthase 
pksH-I Enoyl CoA dehydrases 
pksJ-R “AT-less” type I PKSs 
pksS Cytochrome P450 (hydroxylase) 
    Table 2. Genes of the pksX operon and their supposed functions.7 
 
 
The first and last enzymes of a Type I PKS modular domain would typically be 
ketosynthase and an ACP, per the colinearity rule.7, 17  The six-protein cluster utilizes a 
Type II PKS mechanism instead by way of a non-C-terminal KS enzyme.  Though 
lacking an amino acid residue required for Claisen condensation, it is still capable of 
decarboxylation.  Figure 1.8 illustrates the mechanistic scheme for β-branch insertion 
determined by the Calderone and Walsh research group.23 
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Figure 1.8. Mechanism of β-branch formation.7, 23, 24 
 
 
PksC is an acyltransferase specific for malonyl-CoA, and promotes its transfer to 
the sulfhydryl group of AcpK.  The PksF ketosynthase then catalyzes the decarboxylation 
of the malonyl-ACP to acetyl-ACP.  Next the reaction initiated by the HMG-CoA 
synthase homolog PksG incorporates the β-methyl moiety into bacillaene through a 
critical carbon-carbon bond formation that introduces a single carbon unit for chain  
elongation.23, 24   Condensation occurs between the acetate unit of acetyl-CoA and a β-
ketothioester polyketide intermediary located in PksL, attached to one of its two tandem 
thiolation domains.23  PksH and PksI, both enoyl-CoA hydratases, then catalyze 
dehydration of the hydroxyl group and decarboxylation, respectively, forming a β-
methylated structure.23 
15 
 
I.E.2. Bacillaene Biosynthesis 
 The AcpK/PksFGHI gene “cassette” mimics an isoprene biosynthesis; once the 
product (isoprenyl-S-PksL-2ACP) is constructed, bacillaene is synthesized by the 
remainder of the pksX operon.18, 19, 23  For both pksX and bae, the gen clusters involved 
and the respective portions of the growing bacillaene structure are shown in Figure 1.9. 
 
 
 Figure 1.9. Model of bacillaene biosynthesis.24 
 
 
A linear and highly conjugated structure,  the antibiotic contains both a hexaene, triene, 
and the α-hydroxy-isocaproic acid incorporated by PksJ.24  Multiple stereoisomers of 
bacillaene are observed by LC-MS; with a reduced double bond between C22 and C23, 
dihydrobacillaene is the most prevalent (Figure 1.10.)37 
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Figure 1.10. Bacillaene and dihydrobacillaene.37 
 
 
 Biosynthesis begins with the PKS/NRPS hybrid, pksJ, that lacks four 
characteristics of a typical synthase: acyltransferase domains to introduce monomers for 
chain elongation, a β-ketoacyl synthase domain at the N-terminus, a C-terminal ACP, and 
a conserved aspartate residue in the ketoreductase domain.7  This absent amino acid, a 
trait of all PKS/NRPS split module orthologs, is thought to influence the stereochemistry 
of KR reaction products and so the configuration of any subsequent alterations.7, 24, 30 
 Figure 1.11 is the enzymatic domain structure of pksJ and corresponding portions 
of the growing bacillaene polyketide chain.  In the 1st module, an α-hydroxyl-isocaproic 
starter compound is loaded, and glycine added by the first NRPS domain in module 2.24, 
37  A malonyl unit is added to the chain by ketoacyl synthase in the 3rd module, with the 
resulting ketone reduced to an alcohol by KR.  The alcohol is then eliminated completely 
by dehydratase, resulting in a cis-alkene.  Chain elongation continues in the 4th module, 
17 
 
18 
 
 
1 
2 
3 
4 
5 
Module 
Figure 1.11. Domains of pksJ and the beginning of bacillaene biosynthesis.  Enzymatic domains 
include: A (adenylation), T (thiolation), C (condensation), KS (ketosynthase), ATd (acyltransferase 
docking), DH (dehydratse), and KR (ketoreductase).24, 37 
 
 
while the 5th module is shared with pksL.  This is a split module in which both proteins  
contain an incomplete enzymatic domain; by interfacing at these domains, the two 
proteins share the work of a single module.24
CHAPTER II 
 
PKSX OPERON OF BACILLUS SUBTILIS 
 
 
II.A. Environmental DNA 
 In recent years there has been a renewed focus on natural products as a 
vastly untapped resource for novel antibiotics.  Although an estimated ≤1% of microbes 
worldwide have been studied in depth, they have yielded greater than 17,000 biologically 
active molecules.38  While the remaining 99% is unculturable by known methods, it must 
certainly contain a large number of undiscovered products with biological activity; any 
number of these could be a source of novel pharmacological and/or other clinical 
applications.  Despite difficulties related to culturing these microbes, the isolation of 
bacterial nucleic acids, or metagenomic DNA (eDNA), directly from environmental 
samples is possible and relatively simple.   
Biological sciences often rely on bacterial models to elucidate the specifics of 
biological processes.  Polyketide metabolites, observable throughout nature, possess both 
structural and bioactive diversity.  Discovery of these individual compounds began 
decades ago; it is now known that varying strains of a single bacterial species, such as 
Bacillus subtilis, actinomycetes, and streptomyces, are capable of producing more than 
two dozen antibiotics.25  Although diverse, highly conserved sequence conservation 
exists among specific metabolites.  Consequently, metagenomic methods which survey
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the environment for the sequences responsible for polyketides can yield a large amount of 
data. 
  Despite this opportunity, reconstituting the biosynthesis of polyketides from 
eDNA has not been successful.  However, technological and/or theoretical advances may 
yet open the way for a more complete survey of this environmental microbe assembly.  
DNA sequencing has become a routine and readily available research method, with 
completed genomes accessible for scores of organisms.  Isolated yet unidentified DNA 
sequence regions may now be assessed through sequence homology, giving the 
researcher immediate feedback and a narrowed gene target for further development.   
Numerous methods have been described and utilized to extract and purify eDNA; 
this is a reflection of the variety of environmental samples available, as well as their 
chemical complexity.  Nucleic acid isolation may be done in several ways, yet further 
applications using this material can be difficult because of factors such as impurities.  
Other potential limitations arise from shearing by harsh lysis methods, DNA adsorption 
to soil surfaces, and the coextraction of pollutants.   The most prevalent soil contaminants 
are humic substances and tightly bound soil colloids, both making DNA detection and 
measurement problematic and unreliable.39, 40  
 Due to these obstacles, successful eDNA isolation is not sufficient for 
metagenomic studies – further purification of the sample prior to usage in the laboratory 
is vital.  As with extraction procedures, there are a number of described methods. 
Efficiency and yield of this step helps determine the success of future processing (i.e. by 
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polymerase chain reaction (PCR), restriction enzyme digestion, and subcloning 
efficiency.)40 
II.B. Goals 
We hypothesized that the biosynthetic genes responsible for the β-branch subclass 
found in Bacillus and other known bacteria were sufficiently widespread to be useful as 
highly specific genetic beacons for new polyketide natural products.  By using routine 
laboratory methods, we would be able to dectect pksG-system homologs in local 
environmental samples.  These soils should contain nucleic acids from a large host of 
organisms, and we expected that these were produced by unknown organisms as well as 
the known Bacilli species. 
The first objective of this research was to determine optimal techniques for the 
extraction and purification of bacterial DNA from local soils.  Once achieved, the second 
goal was to obtain environmental genetic data for the β-branching subclass of polyketides 
using existing analytical techniques.  This would be done by specifically using the PCR 
method to survey for the highly conserved pksG homologs described above.  Sequencing 
of these may yield insight into the biosynthetic mechanisms afforded by the conserved 
regions. 
II.C. Results 
Bacterial nucleic acid extraction and purification were done by various methods 
as described herein, with the resulting products used as the template DNA for a PCR.  
Once isolated from soil, DNA may be processed further only after all contaminants are 
removed.  PCRs are thus a rapid way to evaluate the purity of metagenomic extracts; the 
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amplification of multiple target sequences should also provide a means to estimate their 
prevalence in various collected soils. 
  Two PCRs were performed for each eDNA isolate. The first was amplification of 
a 590 base pair (bp) ribosomal RNA sequence, and the second targeted a DNA sequence 
that codes for a conserved amino acid region of pksG homologs shown and highlighted in 
Figure 2.1.  Once amplification was substantiated by agarose gel electrophoresis, the 
PCR products were purified with the QIAquick® PCR Purification Kit from QIAGEN 
Sciences (Valencia, CA).  The target sequences were then subcloned into the Eschericia 
coli pBAD vector via topoisomerase cloning methodology (Invitrogen Corporation).  
This vector confers antibiotic resistance, and so all agar plates and cultures used 
thereafter (except where noted) contained 100 µg/mL ampicillin. 
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PksG  -----------------------MVSAGIEAMNVFGGTAYLDVMELAKYRHLDTARFENL    37 
JamH  -----------------------MQSVGIEALSVYGGAAQLDVRKLVQARQLDISRFDNL    37 
CurD  MPSAIALLLAASIQLYYWARSKAMQQVGIEALSVYGGAAQLELRKLAQARQLDISRFDNL    60 
TaC  -----------------------MGPVGIEAMNAYCGIARLDVLQLATHRGLDTSRFANL    37 
PedP  ------------------------MPVGIEAMNLYGGSAFVDVMELAVYRKHDLSRFDNL    36 
MupH  ----------------------MTRQVGIEAMNVFGGAASLDVTMLARHRKLDSQRFGNL    38 
 
PksG  LMKEKAVALPYEDPVTFGVNAAKPIIDALSEAEKDRIELLITCSESGIDFGKSLSTYIHE    97 
JamH  MMKEKAVSLPYEDPVSYAVNAAKPIIDRLSNADKQRIEMVITCSESGIDFGKSMSTYIQE    97 
CurD  MMKEKAVSLPYEDPVSYAVNAAKPIIDRLSDADKQRIEMVITCSESGIDFGKSMSTYIQE   120 
TaC  LMEEKTVPLPYEDPVTYGVNAARPILDQLTAAERDSIELLVACTESSFDFGKAMSTYLHQ    97 
PedP  LMKQKTVALPYEDSVSFAINAAQPLIDTLSETEKERIELLITCSESGIDFGKSISTYIHH    96 
MupH  LMHEKSVALHSEDPVTFAVNAAKPLIDALSPQERDQIELLITCTESGIDFGKSVSTYVHD    98 
 
PksG  YLGLNRNCRLFEVKQACYSGTAGFQMAVNFILSQTSPGAKALVIASDISRFLIAEGGD-A   156 
JamH  YLGLSRNCRMFELKQACYSGTAGLQMAINLILSQTFPGAKALVIATDISRFLVAEGGE-A   156 
CurD  YLGLSRNCRMFELKQACYSGTAGLQMAINLILSQTFPGAKALVIATDISRFLVAEGGE-A   179 
TaC  HLGLSRNCRLIELKSACYSGVAGLQMAVNFILSGCSPGAKALVVASDLSRFSIAEGGD-A   156 
PedP  YLGLNRNCRLFELKQACYSGTAGLQMAVNFIVSKVSPGAKALVIASDLSRFLVTRDEEGE   156 
MupH  YLGLKKNCRVFELKQACYSGTAGFHSAVQFVLSQTSPNAKALVVAVDLCRFLMIGEGG-A   157 
 
PksG  LSEDWSYAEPSAGAGAVAVLVGENPEVFQIDPGANGYYGYEVMDTCRPIPDSEAGDSDLS   216 
JamH  LSEDWSFAEPSSGAGAVALLVSDTPYIFQVDVGCNGYYGYEVMDTCRPNPDSEAGDADLS   216 
CurD  INYDWSFAEPSSGAGAVALLVSDTPHIFQIDVGCNGYYGYEVMDTCRPNPDSEAGDADLS   239 
TaC  STEDWSFAEPSSGAGAVAMLVSDTPRVFRVDVGANGYYGYEVMDTCRPVADSEAGDADLS   216 
PedP  LTMDWDFFEPSGGAGAIAMLVSEKPDIFELDIGANGYYTYEVMDTCRPIADSEAGNADLS   216 
MupH  AAQDWAFSEPSGGAGAVAMLISDKPHVFSLDIGASGYYSFEVMDTCRPEPDSEAGDADLS   217 
 
PksG  LMSYLDCCEQTFLEYQKRVPGANYQDTFQYLAYHTPFGGMVKGAHRTMMRKVAKVKTSGI   276 
JamH  LLSYLDCCENAYRHYQNRVEGVDYQESFDYLSFHTPFGGMVKGAHRSMMRRLKRAKPADI   276 
CurD  LLSYLDCCENAYRHYQNRVEGVDYRESFDYLSFHTPFGGMVKGAHRNMMRRLKRAKPAEI   299 
TaC  LLSYLDCCENAFREYTRRVPAANYAESFGYLAFHTPFGGMVKGAHRTMMRKFSGKNRGDI   276 
PedP  LLSYLDCCDQSFKEYKKRVFKVDYCDTFQYLCFHTPFGGMVKGAHRNMMRKYSDLSREAI   276 
MupH  LMSYLDCCEQTFNEYRLRVDDVDYARTFDYLAFHTPFGGMVKGAHRLMMRKFAPADPPAI   277 
 
PksG  ETDFLTRVKPGLNYCQRVGNIMGAALFLALASTIDQGRFDTPKRIGCFSYGSGCCSEFYS   336 
JamH  EADFQRRVMPGLVYCQQVGNIMGATLFLSLASTIDNGDFSTPRRIGMFSYGSGCCSEFYS   336 
CurD  EADFQRRVMPGLVYCQQVGNIMGATLFLSLASTIDNGDFSTPRRIGMFSYGSGCCSEFYS   359 
TaC  EADFQRRVAPGLTYCQRVGNIMGATMALSLLGTIDHGDFATAKRIGCFSYGSGCSSEFFS   336 
PedP  EADFQQRVQPGLTYCQRVGNIMGGTIMLSLASTIDNAIMRNTCRVGCFSYGSGCCSEFYS   336 
MupH  EADFAQRVAPGLAYCQRVGNIMGATMFLSLAGIISTARFDEPRRIGCFSYGSGCCSEFFS   337 
 
PksG  GITTPQGQERQRTFGIEKHLDRRYQLSMEEYELLFKGSGMVRFGTRNVKLDFEMIPGIMQ   396 
JamH  GVVTPEGKQIQAQQGISSQLADRYSLSMEEYEQLLYHSSAVAFGTRNVTLDYQLFPGVWK   396 
CurD  GVVTPEGKQIQAQQGISAQLADRYSLSMEEYEQLLYHSSAVAFGTRNVTLDYQLFPGVWK   419 
TaC  GVVTEEGQQRQRALGLGEALGRRQQLSMPDYDALLKGNGLVRFGTRNAELDFGVVGSIRP   396 
PedP  GVVSPSGQAKLRDWALGKHLDSRHRLTMEQYEIVLQRSELVKFGTRNVVLSNDLIPGAWK   396 
MupH  GTVTPQSRDHLSAQAIAQQLDSRYSLSLAEYESILLGNDAVRFGTRDHTVACPVTDSVIA   397 
 
PksG  ---------STQE-KPRLFLEEISEFHRKYRWIS       420 
JamH  ---------QIAG-KGRLVLKAIKEFHREYEWV-       419 
CurD  ---------KIAG-KGRLVLKAIKEFHRKYEWV-       442 
TaC  ---------GGWG-RPLLFLSAIRDFHRDYQWIS       420 
PedP  TITRNVRENKDIDIGKRIFLSEIKEFHRHYEWIE       430 
MupH  ----------AGGLSGKLLLSAINGYHREYSFQP       421  
 
Figure 2.1. Targeted conserved amino acid sequence of pksG homologs. 
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Once target sequences were ligated, the plasmid was transformed into “One Shot® 
TOP10 Chemically Competent E. coli Cells.”  Transformants were grown overnight in 
liquid cultures and screened by PCR for the insert.  If a product of approximately 600 bp 
was amplified, cloning was considered successful.  As a final step, DNA sequencing was 
performed to verify the target insert; this was done by either SeqWright, Inc. (Houston, 
TX) or the Institute for Health, Science, and Society (UNC Greensboro). 
II.C.1. Target Bacterial Regions 
The incidence of pksG homologs in any bacterial population is likely minor, thus 
a positive control reaction was needed to validate each step of the experiment.  A small 
16S ribosomal RNA (rRNA) region is found in all forms of life and, among related 
species, its sequence contains both highly conserved and hypervariable regions.  In order 
to assess the presence, concentration and purity of eDNA prior to pksG screening, a 
conserved 16S region was targeted for PCR.   
Bacterial (BAC) 16S primers (Table 2) were designed to amplify this 590 bp 16S 
rRNA region.  PCRs, using B. subtilis ATCC strains 39374/39320 genomic DNA as a 
template, were performed to confirm primer viability; each produced a band at ~600 bp, 
verifying that the target sequence was a reliable positive control.  Listed at the bottom of 
Table 2 are universal 16S rRNA primers, designated 16S For and Rev, obtained from 
Integrated DNA Technologies (Coralville, IA). 
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Primer Sequence 
pksG degen UP 5’ – CTN CCN TAY GAR GAY CCC GT – 3’ 
pksG degen DN 5’ – NCK RTG NGC NCC YTT NAC CAT – 3’ 
pksG deg2 UP 5’ – ACA CGG TTT GAC AAT CTA ATG ATG VRN SAR AA – 3’ 
pksG deg2 DN 5’ – CAN TAC CTR TGA ACA GCT GGC TAG GGT – 3’ 
BAC 16S Up 5’ – AAG TCG AGC GGA CAG ATG – 3’ 
BAC 16S Dn 5’ – CCA GTT TCC AAT GAC CCT CCC G – 3’ 
Universal 16S For 5’ – AGA GTT TGA TCC TGG CTC AG – 3’ 
Universal 16S Rev 5’ – ACG GCT ACC TTG TTA CGA CTT – 3’ 
Table 3: Primers used for metagenomic survey PCRs.  Abbreviations used: N (any nucleotide), Y 
(any pyrimidine), and R (any purine). 
 
 
These additional rRNA primers were designed to augment a 570 bp region, and meant for 
a secondary control reaction, but resulted in no amplification from eDNA or strains 
39374/39320.   
Degenerate pksG primers were originally designed by Edwards et al., and used 
here with one change in primer sequence.19  The corrected forward primer, pksG degen 
UP, reflects coding DNA for the highlighted “R” in place of a reported “Y.”  Degenerate 
primers target specific amino acids, and for PCR these must be translated into 
complementary DNA sequences for amplification.  Where multiple triple codons may 
encode a single amino acid, PCR primers account for this by including general 
pyrimidine or purine nucleotides.  The highly conserved LPYEDPV sequence was the 
forward primer target; these are the ~46th – 52nd residues of pksG homologs.  The 
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downstream primer, pksG degen DN, was similarily designed to target DNA coding for 
the highly conserved MVKGAHR amino acid sequence that makes up the ~57th – 62nd 
residues of pksG homologs. 
II.C.2. eDNA Isolation 
Three direct extraction techniques were tested on soils collected from various 
areas: wooded and cultivated locations adjacent to the Sullivan Science building of UNC 
Greensboro (Greensboro, NC); a forest, field, and dried creek bed in Greensboro, NC 
park; sand-like sediment from a stream in Falls Park (Greenville, SC); and finally, 
industrial potting soil.   Two commercially available DNA extraction kits were utilized: 
the EPICENTRE® SoilmasterTM DNA Extraction Kit (Madison, WI) and the 
PowerMaxTM Soil DNA Isolation Kit from MO BIO Laboratories, Inc. (Carlsbad, CA).  
A third method was a sodium dodecyl sulfate (SDS)-based extraction described by 
Jizhong Zhou et al. in February 1996.40   
EPICENTRE® SoilmasterTM DNA Extraction: EPICENTRE® required 100 mg 
of soil for a 300 µL yield of eDNA isolate.  Soil was processed per manufacturer’s 
instructions, and initial attempts to amplify 16S and pksG were unsuccessful.  Alterations 
to the procedure included: omission of vortexing steps during extraction to prevent DNA 
shearing, incubating on ice instead of at room temperature during precipitation, and 
extended centrifugation.  Despite these adjustments, no PCR reaction led to 
amplification following eDNA isolation with the EPICENTRE® kit.  
SDS-Based Extraction: Another isolation attempt used a multi-step, SDS-based 
approach:  An initial 5–10 g soil sample yielded greater than 10 mL of isolate solution.  
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The final yield was an amber-colored 500 µL solution.  This coloration was likely due to 
the presence of inhibitory humic substances, and so no PCR was attempted on the isolate.  
Instead, two 100 µL aliquots were purified with commercially available kits, each 
yielding 50 µL.  These were the QIAquick® PCR Purification Kit, and the Wizard® PCR 
Preps DNA Purification System from Promega Corporation (Madison, WI).  An agarose 
gel of the purified samples showed bands above 10 kbp; this indicated DNA presence, 
but all PCR attempts were unsuccessful.  SDS-extracted eDNA was dilute and 
contaminated; even after purification, it was unsuitable for PCR amplification.  This 
prompted use of a third bacterial DNA extraction method. 
MO BIO PowerMaxTM Soil DNA Isolation: PowerMaxTM  required an initial 5–
10 g soil sample and yielded 5 mL eDNA isolate solution.  Manufacturer protocol 
recommended the concentration of 1 mL eluent by ethanol (EtOH) precipitation before 
further processing.  This was done and the eDNA resuspended in 10 mM Tris (pH 8.0) to 
a final volume of 100 µL.  On an agarose gel, the bright band above 10 kbp indicated 
high levels of DNA.  Initial PCRs were performed with Taq Master Mix polymerase; 
although one gel showed faint bands for 16S and pksG at ~600 bp, all attempts at 
subcloning failed, as did efforts to repeat amplification. 
As Taq is particularly sensitive to humic contaminants, PCR was repeated using a 
High Fidelity Phusion polymerase.40  The pksG reaction showed a band near 600 bp; it 
was purified, subcloned, and transformation into TOP10 cells resulted in the growth of 
three colonies.  Each was screened for the pksG insert; only one PCR resulted in a band 
but, at more than 1 kbp, was not the appropriate target.  Sequencing attempts for this 
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product were unsuccessful, and it was determined that the PowerMaxTM enabled 
sufficient amplification but not further processing.  However, as PowerMaxTM extraction 
of eDNA resulted in successful pksG and 16S PCRs, it was used thereafter, unless 
otherwise noted. 
II.C.3. PCR Optimization 
Despite amplification, agarose gel bands of 16S and pksG were barely visible and 
so 1 mL of eDNA was concentrated twice.  The initial 100 µL product was resuspended 
in dH20, and then in 100 µL 10 mM Tris (pH 8.0) after a second EtOH precipitation. 
Resulting DNA had a concentration of 25 µg/mL; by using 4-5 µL (100-125 ng), 16S 
PCR resulted in much brighter gel bands.  Figure 2.2 shows the effects of DNA  
 
 
10 kbp 
2X* 1X 2X 0X 
MW 
standards 
Figure 2.2: Effects of concentrating e DNA and its stability over time.  A single EtOH precipitation 
(1X) increases [DNA]; when repeated (2X), doubly so.  One month at -20ºC (2X*) led to ~50% DNA 
breakdown/loss. 
 
 
concentration on extracted nucleic acid samples, as well as the degradation of eDNA 
during storage.  Although immediately transferred to -20ºC following all experimental 
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procedures, approximately 50% less DNA was noted in a sample that had been stored just 
thirty days as compared to more recent isolate. 
The 16S positive control reaction was, at this stage, considered a reliable and 
repeatable indicator of PCR success; using the same conditions, an initial attempt to 
amplify pksG failed.  Using a High Fidelity Taq polymerase, PCR conditions were 
optimized for pksG amplification.  While monitoring the effects of primer and 
magnesium concentration, PCR products began to show up as blurred gel lanes.  
Conditions were adjusted to minimize streaking, resulting in a reaction recipe that 
included: 100-125 µg eDNA, 0.8-1.0 µM each pksG primer, 2.0 µM MgSO4, and 
anannealing temperature between 34.5ºC and 36.0ºC.  With these parameters, gel streaks 
were concentrated around the 550-700 bp region, but were still too delocalized for 
cloning. 
To improve precision, a second set of degenerate primers, pksG deg2 UP and 
pksG deg2 DN, were designed.  As they target the same 600 bp region, these were meant 
to be used as a set or in conjunction with the original pksG primers.  The degenerate 
primers, still targeting the above conserved amino acid sequences, contained different 
nucleotides than the first set, in an attempt to maximize the possibility of different bases 
encoding for the desired residues.  As the conserved amino acid region was the same, it 
was hypothesized that increasing the degeneracy of the primers would improve the 
chances of PCR success.  No amplification was achieved with any primer combination, 
despite optimization attempts. 
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II.C.4. eDNA Purification 
MO BIO PowerCleanTM DNA Clean-Up: One possible explanation for both the 
non-specific pksG bands and low concentration of 16S products, was the presence of 
coextracted inhibitors in our eDNA samples.  The PowerCleanTM DNA Clean-Up Kit 
from MO BIO was used to purify isolates; via spin column filtration with three wash 
buffers, organic and non-organic matter was precipitated out of 150 µL extract to a final 
50 µL yield.  It was noted that, if used to purify the isolate immediately after extraction, 
no DNA band was detectable on an agarose gel.  The kit was found to be effective only 
after a 2x EtOH precipitation of the crude extract; resulting eDNA had a concentration of 
20 µg/mL and PCR amplification was markedly improved.  Following PowerMaxTM 
extraction, 2 x EtOH precipitations, and PowerCleanTM purification, PCRs resulted in 
a bright band at ~600bp for 16S, and a faint but distinct band at ~600 bp for pksG.   
Each purified PCR product was successfully subcloned into pBAD with 
subsequent transformation; 16S transformants were screened, and insert presence verified 
by DNA sequencing.  Transformation of pksG resulted in 34 colonies.  All were 
screened, and PCRs showed three different products – one was potentially accurate for 
pksG at ~600 bp, thirteen were between 200-300bp, and the remaining 20 were ~1300bp.  
Plasmid concentration varied from 15-90 µg/mL, which was insufficient for DNA 
sequencing; using 10 mL inoculated cultures increased the range to 75-315 µg/mL.  
Sequencing attempts were unsuccessful for all three products. 
Gel Purification: Around this time an article by Professor Sean Brady at 
Rockefeller University appeared in Nature Protocols, and described an electroelution 
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method for purifying crude eDNA extracts.41  Based on this, 170 µL eDNA isolate, from 
soil obtained at UNC Greensboro, was loaded into a 1% agarose gel that contained no 
ethidium bromide.  To prevent the oily isolate from floating into solution, the gel was run 
at 100V for 1 h until samples were absorbed into the agarose; the gel was then submerged 
in buffer and run for an additional 45 minutes.  One lane was excised and stained with 
ethidium bromide until a band was visible at ~1-2 cm from the top.  The portion of 
unstained gel containing DNA was excised and put in dialysis tubing with 10 mL 0.5x 
Tris/boric acid/EDTA (TBE) buffer.  Submerged in buffer, a 100V current was run 
perpendicularly through the tubing for 2.5 hours.  Following centrifugation to remove gel 
residue, 10 mL of solution remained.  Two EtOH precipitations of a 1 mL aliquot 
resulted in DNA with a 15 µg/mL concentration. 
The eDNA obtained from each purification technique was similar in 
concentration, yet electroelution provided 100 µL eluent as opposed to 50 µL from 
PowerCleanTM .  To compare inhibitor removal abilities of the two methods, PCRs were 
performed using reaction conditions as described by J.R. Spear et al.42  The 16S rRNA 
products seen in Figure 2.3 verified that both methods were successful at purifying  
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MO BIO 
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standards
Figure 2.3: eDNA sample purity and concentration following gel purification.  Both were similar 
following either method, and bands at ~600 bp verify 16S rRNA amplification. 
 
 
extracted DNA, and with comparable results.  It should be noted that 10 g of the sand/soil 
collected from Falls Park in Greenville, S.C. was prepared by PowerMaxTM extraction, 
gel purification, and 2 x EtOH precipitations.  Resulting eDNA had a 40 µg/mL 
concentration, twice that of any soils collected locally; however, no pksG amplification 
was observed using that sample. 
 Using gel-purified eDNA, PCR optimization of pksG was repeated.  A reaction 
mixture of 75 µg DNA, 5µg BSA, 0.8-1.0 µM each primer, and 2.0 µM Mg2+, resulted in 
250 bp and 400 bp products.  Sequencing showed that pksG degen UP served as both the 
forward and reverse primer in these PCR reactions.  Homology screening using BLAST 
(Figure 2.4) revealed that the translated 400+ bp region showed 31% identity, 51% 
positive match to an E. coli putative carbohydrate kinase; a translated protein sequence 
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from the 250 bp product was had 21% identity, 42% positive match to a bacterial α-
rhamnosidase. 
 
 
Figure 2.4. Homology results for the two eDNA-pksG sequences. 
 
 
II.D. Conclusions 
 Access to nucleic acids from bacteria living in soil is hindered by the complex and 
diverse components of all soil types.  Simple screening techniques such as PCR are 
possible, but only after careful preparation of collected samples.  Preparing eDNA must 
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be done in a way that benefits research goals, specifically by adapting the procedure to 
access target molecules.  Based on the success of 16S rRNA control reactions, we have 
concluded that SDS-based and PowerMaxTM extraction of crude eDNA are effective 
methods for soils collected in our region of North Carolina.  The SDS yield is twice that 
of the kit, and so more appropriate for larger-scale trials.  To access Gram-positive 
bacteria, crude extract purification by agarose gel electrophoresis and a 100-fold eDNA 
concentration increase are sufficient preparation for a PCR survey. 
 In comparison to the control reaction, all attempts to amplify pksG HMG-CoA 
homologs were unsuccessful.  We concluded that the relatively small β-branching 
polyketide population was not well-represented in our purified eDNA samples for one of 
two reasons; these metabolites are either absent from the local soil population or exist in 
such small amounts that detection is not possible with the described procedure. 
II.E. Future Metagenomic Work 
 In order to pursue the β-branch polyketides further, a cosmid library of the 
environmental nucleic acids present in local soils could be constructed.  By obtaining a 
large amount of DNA and cloning it into an expression host, it would be feasible to 
identify clone-specific molecules with antibacterial activity.  An alternative host system 
with different expression capabilities may also benefit, to ensure that there are no 
heterologous expression difficulties.     
 The above techniques may also be used to screen for other classes of molecules.  
Future targets may include β-lactams, lantibiotics, and aminoglycosides.   Additionally, 
other types of environmental samples are available for β-branch polyketide screening.  
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There are many other types of soil in North Carolina alone, varying by region and 
bacterial content. Also, microbial communities are to be found in other sediments and 
water; all of these are possible areas for future work. 
II.F. Experimental 
II.F.1. eDNA Extraction 
 EPICENTRE® SoilmasterTM DNA Extraction: All soils were collected by the 
author using sterile technique, and stored at 4ºC for up to one month.  Approximately 100 
mg of four soils from Greensboro, NC were processed as follows: the EPICENTRE® 
SoilmasterTM DNA Extraction Kit used a hot, SDS-based detergent and proteinase K at 
65ºC for chemical and enzymatic cell lysis, respectively.   Proteins were then precipitated 
out of the solution, followed by spin column chromatography to remove inhibitors.  The 
extracted DNA was resuspended in 300 µL of 10 mM Tris-HCl (pH 7.5), 1 mM EDTA. 
Using this as template DNA, initial PCRs were unsuccessful.  Alterations to the 
procedure included: omission of vortexing steps during extraction to prevent DNA 
shearing, incubating on ice instead of at room temperature during DNA precipitation, and 
extended centrifugation.  Despite these adjustments, no PCR reaction resulted in a 
product. 
 SDS-based extraction: For SDS-extraction, 13.5 mL extraction buffer (100 mM 
Tris-HCl, pH 8.0, 100 mM Na-EDTA, pH 8.0, 100 mM Na·phosphate, pH 8.0, 1.5 M 
NaCl, 1% hexadecylmethylammonium bromide) and 20 µL proteinase K (50 mg/mL) 
were mixed with 5.0 g soil by horizontal shaking for 30 minutes (37ºC, 225 rpm).   DNA 
was extracted by adding 1.5 mL 20% SDS and incubated for 2 h (65ºC), during which the 
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tube was inverted every 20 min to mix.  Supernatant was removed to a sterile tube 
following centrifugation (10 min, 6,000 x g).  The remaining soil pellet was extracted 
twice more by adding 4.5 mL buffer and 0.5 mL 20% SDS, vortexing for 10 s, incubating 
at 65ºC for 10 min, and centrifuging as before.  All three supernatants were combined to 
12.5 mL in a clean tube; 12.5 mL of 24:1 vol/vol chloroform-isoamyl alcohol was added 
and the aqueous phase removed after a 10 min centrifugation.  DNA was precipitated by 
adding 0.6 vol isopropanol and incubating 1 h at room temperature.  After centrifuging 
(20 min, 16,000 x g), supernatant was removed, the brown pellet washed once with cold, 
70% ethanol, and resuspended in 500 µL dH2O. 
 As the crude extract was amber in color, 100 µL was purified using a vacuum 
manifold and the Wizard® PCR Preps System.  The 50 µL eluted with sterile H2O had a 
very faint tan-colored appearance, and the procedure was repeated.  Another 100 µL of 
extract was purified with the QIAquick® PCR Purification Kit; although clear and 
colorless, the 50 µL eluent was processed again.  Loaded directly into a 1% agarose gel, 
each sample showed DNA presence by a bright band located above 10 kbp.  No PCR 
amplification was achieved with 16S rRNA or pksG primers. 
 MO BIO PowerMaxTM Soil DNA Isolation: Next we obtained the PowerMaxTM 
Soil DNA Isolation Kit.  Soil is first added to a “bead-beating” tube to disperse particles 
and protect nucleic acids.  After SDS-based cell lysis and 2 x EtOH precipitations, eDNA 
is bound to a salt solution for spin column chromatography.  With the 100 µL isolate, a 
very faint band was seen above 10 kbp.  To concentrate this, 1 mL crude extract was 
mixed with 0.04 mL NaCl (5 M), 2.1 mL cold 100% ethanol, and centrifuged (30 min, 
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13.2 rpm).   Supernatant was decanted, the pellet washed twice with cold, 70% ethanol, 
and resuspended in 100 µL sterile, 10 mM Tris. 
II.F.2. PCR Optimization 
 All polymerase chain reactions were performed in a thermocycler, and cooled to 
4.0 ºC after completion.  For agarose gel electrophoresis of each PCR product, 16 µL was 
mixed with 4 µL loading dye, and the 20 µL solutions loaded into a 1% agarose gel 
containing 9 µL ethidium bromide.  Gels were run at 120V to completion, bands viewed 
by UV light and their size determined by standard molecular weight markers. 
Taq Master Mix: With the concentrated extract as template DNA, 16S rRNA and 
pksG were amplified using Taq® Master Mix from InvitrogenTM.  The reaction conditions 
were: a 2 minute “hot start” incubation at 94.0ºC, then 30 cycles of 30 s at 94.0ºC, 30 s at 
55ºC for 16S and 45.0ºC for pksG, and 1.5 min at 65.0ºC.  A faint band was noted around 
600 bp for each PCR product; however, both PCRs were repeated twice with no observed 
product. 
 Phusion Polymerase: The same eDNA template was used for PCR with a high 
fidelity Phusion polymerase from New England BioLabs®, Inc.  Reaction conditions were 
adjusted to: one 30 s hold at 98.0ºC, then 30 cycles of 98.0ºC for 10 s, 60.0ºC for 30 s, 
and 30 s at 72.0ºC, followed by a 5 min elongation hold at 72.0ºC.  The 16S product 
showed indistinct streaking, and there was no band for pksG. 
 To improve these results, 1 mL crude eDNA extract was concentrated as above 
and resuspended in 100 µL dH2O; to this, 2 µL 5M NaCl and 104 µL cold, 100% ethanol 
were added before centrifugation (30 min, 13.2 rpm).  The pellet was washed as before, 
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and resuspended in 100 µL sterile, 10 mM Tris.  A repeat PCR of both target regions 
resulted in a band at ~600 bp for 16S, but none for pksG.   
 Taq High Fidelity Polyemerase: A High Fidelity Taq® polymerase was obtained 
from InvitrogenTM to optimize pksG PCR conditions; reaction conditions were identical 
to those using Taq Master Mix.  The following parameters were varied: Mg2+, primer, 
DNA, dNTP, bovine serum albumin (BSA), and DMSO concentrations, as well as 
annealing temperatures.  The 16S primers were used for each trial, and conditions 
resulting in the brightest band (i.e. highest amount of amplification) were considered 
optimal. 
 During trials, PCR products started to show extensive streaking in gel lanes; once 
this was minimized, samples exhibited a broad “band” concentrated at the 600-700 bp 
region and were processed further.  The PCRs contained: 100-125 ng eDNA, 3 µL of 
each 10 µM primer, 40 µL of a 50 mM Mg2+ solution, and 200 µM dNTP’s.  Addition of 
BSA or DMSO did not enhance amplification.  For reactions that resulted in these broad 
bands, the pksG PCR product was purified with the QIAquick® PCR Purification Kit. 
II.F.3. Initial TOPO Cloning Attempt 
 The pBAD TOPO® TA Expression Kit from InvitrogenTM was used in an attempt 
to clone and overexpress the purified pksG PCR product.  As the vector confers antibiotic 
resistance to the bacterium, all agar plates and starter cultures were prepared with Luria-
Bertani media (0.5% yeast, 1.0% Bacto tryptone, 1.0% NaCl) and contained 100 µg/mL 
ampicillin.    
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4 µL of the pksG insert was mixed with 1 µL TOPO® cloning vector, a standard salt 
solution, and incubated at room temperature for 15 min.  Of this mixture, 2.0 µL was 
added to competent “TOP10®” cells, incubated on ice for 30 min, at 42.0ºC for 2 min, 
and 250 µL LB broth was added.  Cells were shaken horizontally for 1 h (37.0ºC, 225 
rpm), then 50 µL was spread over an agar plate.  Following 24 h incubation at 37.0ºC, the 
plate had three colonies (G1, G2, and G3) and was stored at 4ºC. 
 All three colonies were grown on fresh plates, and used to inoculate 5 mL starter 
cultures that were shaken overnight (225 rpm, 37.0ºC).  Following purification the next 
day, 1 µL of each was used as DNA template for PCR.  Only G3 showed a product, and at 
~1400 bp was a possible dimer of pksG that occurred during amplification.  New G3 
cultures were purified and combined to a concentration of 260 µg/mL; DNA sequencing 
revealed no match to the pksG target insert. 
II.F.4. eDNA Purification 
 To remove any coextracted inhibitors, 150 µL of PowerMaxTM eDNA isolate was 
purified with the PowerCleanTM DNA Clean-Up Kit from MO BIO Laboratories.  With 
4–5 µL of the 50 µL eluent as template DNA, PCRs for 16S and pksG resulted in bands 
around 600 bp.  Following PCR clean-up and TOPO® cloning, 34 transformants were 
screened for the pksG insert.  Of these, one was ~600 bp, 10 were between 200-300 bp, 
and the remaining around 1300 bp.  Eight of the 1300 bp samples were digested using 
MspI and HindIII restriction endonucleases.  After 3.5 h incubation at 37ºC, samples 
were heat-deactivated for 20 min at 65.0ºC, and loaded into a 2% agarose gel.  No bands 
39 
 
were seen for any reaction.  DNA sequencing on each of the three TOPO® products was 
unsuccessful. 
 An eDNA purification procedure described by Sean F. Brady was performed in an 
attempt to eliminate coextracted inhibitors.41  A 1% agarose gel was prepared with 0.5x 
TBE buffer (45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 8.0) and no ethidium 
bromide.  The initial attempt to load crude extract failed, as the oily solution floated up to 
the buffer surface.  Per a Brady recommendation, a gel was placed in the apparatus with 
TBE buffer up to the gel surface but not covering the loading wells.41  170 µL crude 
extract was heated for 35 min at 50ºC, loaded, and run in the gel for 30 min at 100V.  
Once eDNA was absorbed, the gel was submersed in TBE buffer and run for an 
additional 45 min. 
 A lengthwise piece of the gel containing one lane of eDNA, was excised and 
placed in 100 mL TBE buffer with 10 µL ethidium bromide.  After mixing for 2 h, a 
bright band was noted by UV light at ~ 1-2 cm from the well; per this location, the 
corresponding portion of unstained gel was excised and placed in dialysis tubing with 10 
mL TBE.  (After staining the remaining gel pieces, it was noted that a significant amount 
of DNA remained in the agarose.)  With the dialysis tubing placed perpendicularly to a 
100 V current for 2.5 h, eDNA was electroeluted out of the agarose; resulting buffer was 
centrifuged for 10 min to remove gel residue, leaving 10 mL DNA solution.  Using 1 mL 
of this, a 2x concentration was performed and the 100 µL product contained 15 µg/mL 
eDNA. 
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II.F.5. Final pksG Amplification Attempt 
 A literature search revealed PCR parameters to amplify 16S rRNA samples 
similar to those described above.42  A control PCR using BAC 16S primers and B. 
subtilis 39374 led to a bright, distinct band near 600 bp.  Using eDNA from both 
PowerCleanTM and gel purification, two PCRs were mixed with Taq Master Mix to 
contain: 200 ng eDNA, 0.5 µL each BAC 16S primer, 0.25 µM Mg2+, and 5 µg BSA.  
Reaction conditions were: a 2 min, 94.0ºC hot start, followed by 30 cycles of 30 s at 
94.0ºC, 1 min at 55.0ºC, 1.5 min at 72.0ºC, and a final 12 min incubation at 72.0ºC.  Both 
amplified successfully, with bands at ~600 bp of similar intensity. 
 The concentration of pksG primers and Mg2+ was varied in multiple PCRs to 
complement adjusted reaction conditions, and the annealing temperature decreased to 
45.0ºC.  With 3.0–4.0 mM MgCl2 and 0.8–1.0 µM of each primer, two bands were seen 
for each reaction; a bright, distinct band at ~400 bp, with another near 250 bp that was 
noticeably fainter.  TOPO® cloning products of each were sent for DNA sequencing, and 
the results are shown in Figure 2.4. 
II.G. Cloning, Overexpression and Purification of the PksJ Protein 
II.G.1. Background 
The product of pksX and the bae ortholog is dihydrobacillaene, rather than its 
dehydrogenated counterpart bacillaene.37  Per modular enzyme synthesis (Table 1), an 
enoyl reductase should be included in the 3rd module of pksJ for this structural moiety.  
Of particular interest is the unusual method by which pksJ processes a β-keto moiety to 
an α,β-enoyl.  Rather than subsequent reduction and dehydration to produce the cis-
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alkene structure, the growing chain is transferred between two tandem thiolation domains 
prior to DH activity. 
It was hypothesized that a trans-ER of the PksE flavoprotein reduces the C22-C23 
double bond.7  At the request of Dr. Jörn Piel, University of Bonn, Germany, our goal 
was to isolate, overexpress, and purify the PksJ protein.  Once a protein scaffold of the 
tandem thiolation domains and substrate analog were available, his research group hoped 
to demonstrate the bond reduction and perform activity characterization. 
II.G.2. Results 
 A 535 bp region of the pksJ gene was amplified from B. subtilis 168 by PCR and 
successfully cloned into the pET-28a plasmid via the NcoI and XhoI restriction sites.  
Ligation products were transformed into competent E. coli DH5α cells, incubated 
overnight, and individual colonies used to inoculate starter cultures.  Once the pET-
28a/pksJ plasmid was purified from DH5α, it was retransformed into E. coli BL21(DE3) 
cells for the purpose of overexpression. 
Positive transformants were used to inoculate starter cultures and added to 1L 
Luria-Bertani media.  The OD595nm of this large culture was monitored until it was 
between 0.500 and 0.600, and pksJ overexpression was induced with isopropyl-β-D-
thiogalactopyranoside (IPTG).  Following an overnight incubation, cells were recovered 
by centrifugation. 
During the cloning process, a 6x Histidine tag was added to the protein via the 
pET-28a C-terminus.  This allowed for pksJ purification by a nickel-nitrilotriacetic acid 
(Ni-NTA) affinity column.  Once the overexpression cells were applied to the column, it 
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was washed with 60 mM imidazole and eluted in 1 mL fractions.  Using a Bradford 
reagent assay at 595 nm, fractions 2 and 3 had an absorbance of 0.195; a 10% SDS-
PAGE gel showed no band for either fraction. 
Using PksJ protein from a new overexpression culture, purification by Ni-NTA 
column chromatography was repeated.  Fractions 2 and 3 showed A595nm of 0.518 and 
0.423, respectively.  A 15% SDS gel showed thick bands around the 20 kDa marker; the 
PksJ protein was present but samples were saturated and assumed to contain impurities.  
The affinity column purification procedure was repeated twice, using differing imidazole 
concentrations in the wash buffer solution.  At 140 mM imidazole, the protein product 
was not present in eluted fractions and was believed to have been washed out of the 
column.  With a 90 mM imidazole wash buffer, the eluted protein band was more 
concise, yet still appeared to contain impurities. 
Before Dr. Piel was able to complete the scaffold synthesis and utilize the purified 
PksJ protein, the Christopher Walsh group demonstrated that the trans-ER of PksE 
reduces the double bond of dihydrobacillaene to produce the bacillaene antibiotic.43 This 
was possibly due to the tandem thiolation domains; it was reported that kinetic analysis of 
this reaction will be forthcoming. 
II.G.3. Experimental 
Cloning: Bacillus subtilis 168 cells were streaked on an LB-agar plate and 
incubated overnight at 37ºC.  One colony was used to inoculate a 5 mL LB culture that 
was shaken at 37ºC and 225 rpm.  The following day, B. subtilis 168 genomic DNA was 
isolated with the Wizard® Genomic DNA Purification Kit from Promega. 
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Primers were designed to augment a 535 bp region of pksJ; these were a forward 
primer, 5’ – CAAACTAGAACCATGGAAGCAGCCTTAATC – 3’ with NcoI sequence, 
and the reverse 5’ – AGGGTGTCCTCGAGTTCAACGGTC – 3’ with XhoI sequence.  
Each primer was mixed with B. subtilis 168 genomic DNA, dNTP’s, 50 mM MgSO4, and 
a high fidelity Taq polymerase.  The PCR conditions were: 94.0 ºC hot start for 2 min, 
then 30 cycles of 30 s at 94.0ºC, 30 s at 54.0ºC, and 1 min at 68.0ºC, then cooled to 
4.0ºC.  A 1% agarose gel confirmed pksJ with a band slightly above 500 bp, and the PCR 
product was purified with the QIAquick® PCR Purification Kit.   
On an LB-agar plate containing 30 µg/mL kanamycin, DH5α/pET-28a cells were 
grown overnight at 37ºC.  One colony was used to inoculate a starter culture of 5 mL LB 
containing 30 µg/mL kanamycin, and shaken overnight (37ºC, 225 rpm).  The culture 
was purified the next day with the QIAprep Spin Miniprep Kit. 
 The purified pET-28a plasmid and pksJ PCR product were both digested at 37ºC 
for 3.5 h, using the NcoI and XhoI restriction enzymes.  Following a 65.0ºC heat 
deactivation for 20 min, both were purified by a 0.7% low-melting agarose gel run at 
4.0ºC.  Each band was excised and placed in a 75.0ºC water bath until the agarose had 
melted.  With 1µL T4 DNA ligase, 2µL buffer, and H20, five reactions were mixed with 
different insert:plasmid ratios (in µL) of 1:1, 1:3, 3:1, 2:8, and 8:2.  These were ligated in 
a thermocycler by three incubation periods: 30 min at 37.0ºC, 2 h at 23.0ºC, then 
overnight at 16.0ºC. 
Following heat-deactivation (20 min, 65ºC) the next day, each 20µL ligation 
product was mixed with 100µL competent DH5α cells.  After 30 min on ice, cells were 
44 
 
heat shocked, 1 mL LB added, and incubated for 1 h at 37ºC.  Following centrifugation (5 
min, 8,000 rpm), 1 mL supernatant was removed and the remainder plated on kanamycin-
agar plates.  All five plates were incubated overnight at 37.0ºC; except for 1µL:1µL, all 
insert:plasmid ratios resulted in multiple colony growth.  Four were used to inoculate 
cultures containing 5 mL LB with 30 µg/mL kanamycin and grown overnight.  Once 
purified, PCR screening of all four samples confirmed the pksJ insert. 
Overexpression: E. coli BL21(DE3) cells were grown overnight at 37.0ºC on an 
LB-agar plate.  A starter culture was shaken at 225 rpm, 37.0ºC overnight; 50 µL of this 
was added to 5 mL LB the following morning, grown until cloudy, and made chemically 
competent.  To 100µL competent BL21(DE3) cells, 1µL of a purified pksJ/pET-28a 
culture was added and incubated on ice for 30 min.  Following a 2 min heat shock at 
37.0ºC and 10 min at room temperature, 1 mL LB was added and the mixture incubated 
for 1 h at 37.0ºC.  The sample was centrifuged at 8,000 rpm for 5 min, 1 mL supernatant 
was removed, and 20µL plated on agar plates containing 30 µg/mL kanamycin. 
Following an overnight incubation at 37.0ºC, one colony was used to inoculate a 
starter culture of 5 mL LB and 30 µg/mL kanamycin, which was shaken at 220 rpm and 
37 ºC.  The next morning, 2mL of the starter culture was added to 1L sterile LB media, 
along with kanamycin to a final concentration of 30 µg/mL.  The overexpression culture 
was shaken at 225 rpm, 37.0ºC until the OD595nm reached 0.530, and then induced with 
0.63 mM isopropyl-β-D-thiogalactopyranoside (IPTG).  After induction, the culture was 
grown overnight (37.0ºC, 225 rpm).  The sample was centrifuged the next day for 30 min 
at 6,500 rpm; supernatant was discarded and the pellet stored at -80ºC.   
45 
 
46 
 
Purification:  The pellet was resuspended in 20 mL of 1x binding buffer (5 mM 
imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9).  This solution was sonicated for 3 
min to lyse the protein, and centrifuged for 30 min (15,000 x g, 4ºC).  Approximately 17 
mL supernatant was syringe filtered, and loaded onto a Ni-NTA column.  Once adsorbed, 
20 mL of 1x binding buffer was used to wash the column; a second wash was performed 
with 12 mL of 1x wash buffer (60 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 
7.9).  The protein was eluted in 1 mL fractions with 12 mL of 1x elute buffer (1 M 
imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9).  
From each 1 mL fraction, 33 µL was added to 1 mL Bradford reagent, and 
absorbance recorded at 595 nm to assess protein concentration.  Fractions 2 and 3 had an 
absorbance of 0.518 and 0.423, respectively; 20 µL was combined with 80 µL SDS 
buffer and run in a 15% SDS-PAGE gel.  The two bands at ~20,000 Da were indicative 
of saturation.  Column chromatography was repeated using a wash buffer with 140 mM 
imidazole, yielding no protein.  The next step would have been to optimize the imidazole 
concentration of the wash step to reduce saturation and yield a pure PksJ protein.
CHAPTER III 
BACILLUS TAXONOMY 
 
III.A. Background 
III.A.1. Classification of Bacilli 
There are more than 200 known species of the Bacillus genus, and 
microbiologists have worked for decades on their taxonomic classification.44  
Historically, biochemical and morphological properties formed the basis for this before 
the advent of DNA sequencing.  The current trend is a focus on variability in regions of 
the non-coding 16S rDNA gene, which is important for DNA transcription and is highly 
conserved among similar groups of eukaryotes and prokaryotes alike.  The ability of a 
bacterial strain to produce specific aromatic polyketides has also been suggested as an 
additional means of classification.45, 46  Horizontal gene transfer is known to occur 
between bacteria, and may result in two species sharing the same biosynthetic capabilities 
(such as homologous PKS gene clusters). 
III.A.2. B. subtilis and B. amyloliquefaciens 
 Bacillus amyloliquefaciens is a Gram-positive bacterium that was originally 
mistaken for B. subtilis, but is now known to differ in its ability to suppress pathogenic 
organisms and stimulate plant growth.7  The closely related B. amyloliquefaciens has also 
been found to produce the antibiotics difficidin and bacillaene.  These are coded for by 
two of three large PKS gene clusters (difN and baeG, respectively), whose sequences 
have been reported by Chen et al.7  The first of these clusters, pks1 or bae, is a known 
47 
 
ortholog of the pksX operon of B. subtilis, thought to be present due to either horizontal 
transfer or a common ancestor. 
 ATCC strains 39374 and 39320 of B. subtilis were shown to produce difficidin in 
1987, as described earlier.  While working with ATCC strain 39374, a probable pksG 
homolog was successfully amplified and sequenced.  This was compared to the published 
genome for B. subtilis strain 168, and to B. amyloliquefaciens FZB 42.  Based on the 
results, it was suspected that the ATCC strains had been misclassified and further 
analysis was conducted.    
III.B. Results 
III.B.1. PksX Presence  
 The probable homolog from strain 39374 was successfully amplified using pksG 
degenerate primers described in Chapter 2.  This was then subcloned into pBAD via 
topoisomerase-TA cloning methodology and ten transformants were used to inoculate 
starter cultures.  The following day each was purified, and PCR repeated to verify the 
pksG insert.  DNA sequencing was obtained for one positive transformant and compared 
to both pksG from B. subtilis strain 168 and to the baeG gene of B. amyloliquefaciens 
FZB 42.  This sequence showed an 89% coded positive identity and 98% similarity with 
strain 168 pksG, and the coded amino acid sequence was a 100% match to FZB 42 baeG, 
with a 98% DNA sequence equivalence.   
 A PCR was repeated using strain 39320 and the same pksG degenerate primers; 
subcloning and screening techniques were repeated and a DNA sequence was obtained.  
This had a 97.5% match with baeG, with 594 of 609 equivalent nucleotides; the 
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converted amino acid sequence was a 99% identity and 100% similarity match.  
However, there were four more mismatched amino acids when compared to B. subtilis 
168.  
 A former colleague, Suzette Mills, used primers specific to the difCNO genes for 
PCR amplification with strains 168, 39374, and 39320.  Agarose gel showed that all three 
primer sets successfully amplified a genomic region from both ATCC strains, and no 
products when strain 168 was the DNA template for the reaction.  Since the dif PKS 
cluster is present only in B. amyloliquefaciens, this was considered further indication of 
the misclassification of these two strains as B. subtilis. 
III.B.2. rRNA and rDNA  
 Ash et al. identified a conserved region of rRNA that is 98.3% similar between 
the B. subtilis and B. amyloliquefaciens species.47  Within this are two hypervariable 
regions (nucleotides 59-79 and 625-64); classification of strains within the two species is 
possible based on single nucleotide polymorphisms within these regions.  Primers 
Bsub5F and Bsub3R were used in PCRs with strains 39374 and 39320 as template 
DNA.48  Agarose gel electrophoresis verified a product of ~600 bp; after subcloning into 
the pCR®4 vector from InvitrogenTM, Inc., DNA sequencing was obtained for each 
sample, and showed a 99% match to B. amyloliquefaciens FZB 42, as compared to a 98% 
match to B. subtilis 168 (Table 4).   
49 
 
 
 NUCLEOTIDE POSITIONS  
Strain 70 126 180 185 198 202 271 285 465 472 483 GenBank 
168 A T G T T A T A A G T D88802 
FZB 42 G T G T T G C G G A C AY055221
39320 G T G C T G C G G A C EU564529
39372 G T G C C G C G G A C EU564530
Table 4: Sequence results for 16S polymorphisms.  GenBank Accession numbers are included for 
each. 
 
 
 An additional hypervariable section of DNA, known as the intergene region 
(IGR), is found between the 16S and 23S ribosomal regions and varies by bacterial strain.  
However, the rDNA on each side of the IGR (the 16S 3’ end and 23S 5’ end) is highly 
conserved and species-specific.  Multiple copies of the same IGR may be found in the 
same bacterium that, when amplified by PCR and run on a gel, result in a “fingerprint” 
pattern.49  Taxonomic classification of individual strains may be rapidly assessed by 
determining the number and size of IGR copies. 
 An IGR fingerprint of B. subtilis is known to vary from related species by slight 
differences in the bands between 250 bp and 500 bp, and the band at ~640 bp.  Whereas 
B. subtilis typically shows a single band at 430 bp, B. amyloliquefaciens also has bands at 
320 bp, 360 bp, and 650 bp.  Primers 16S-23S Up and 16S-23S Dn were designed to 
amplify an ~400 bp IGR region, and used for PCRs with ATCC strains 39374 and 39320  
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Figure 3.1. Intergene regions of strains 39374 and 39320.  Gel on the left shows PCR products for 
ATCC strains.  Gel on the right shows previously resolved fingerprint patterns of B. subtilis (left 
lane) and B. amyloliquefaciens (right lane).50 
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as the templates.51, 52  Figure 3.1 shows the resulting agarose gel, with identical bands for 
both strains at ~350-400 bp, 500 bp, and ~650 bp.  Each 350-400 bp band was excised, 
purified, and subcloned into a sequencing vector.  Positive transformants were sent for 
DNA sequencing, and were a 100% match to each other.  The broad “fingerprint” bands 
between 300-400 bp along with the absence of a band at ~640 bp, was a match for B. 
amyloliquefaciens IGRs reported by the Daniele Daffonchio research group in Milan, 
Italy.50 
Six additional single nucleotide polymorphic (SNP) positions were identified in 
the 16S rDNA region that distinguish between the two species.53  For ATCC strains 
39374 and 39320, each nucleotide corresponded with the B. amyloliquefaciens FZB42 
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sequence rather than B. subtilis 168.  These are shown in Table 4 as positions 202, 271, 
285, 465, 372, and 483. 
III.B.3. Detection of Specific Sequences 
 One difference between the two Bacillus species is the α-amylase enzyme that 
each produces; the B. subtilis gene is referred to as amyS, while amyA refers to B. 
amyloliquefaciens.  The lack of homology between these two genes makes them a useful 
tool for distinguishing the taxonomy of individual strains.53  The forward PCR primer 
ABa3 and reverse primers ABa4 and Abs3, specific for B. amyloliquefaciens and B. 
subtilis respectively, were used in reactions with strains 168, 39374, and 39320.53 
PCR primers OTA1 and OTA2 were designed to amplify a second gene, thyA, 
that encodes for a thymidylate synthase found in B. subtilis only.53 Agarose gel 
electrophoresis (Figure 3.2) showed that the amyS and thyA genes were amplified only 
from strain 168.  No PCR product was detected for the amyA reactions; in addition to the 
SNP difference at position 185 for the ATCC strains, this indicates that they are more 
closely related to a related B. amyloliquefaciens subtype known to lack the amyA gene.54 
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Figure 3.2. ThyA and α-amylase genes.  PCR amplification of thyA was successful with strain 168 
only (left).  Neither amyA or amyS (right) were detected in strains 39320 (lanes 1 + 5) and 39374 
(lanes 2 + 6).  Strain 168 (lanes 4 + 7) showed presence of amyS. 
 
 
An additional difference between the two species is the arrangement of 
nucleotides around the tetB genes that encode for an anti-porter membrane protein.54  The 
reverse TetB_R primer was designed to complement the 5’ end of the gene, identical for 
both species.  PCR primers YyaO_F and YyaR_F, specific to the 3’ ends of B. subtilis 
and B. amyloliquefaciens respectively, were used in conjunction for reactions with all 
three strains.54  As expected, YyaO_F/TetB_R yielded a product with strain 168 only, 
while YyaR_F/TetB_R amplified a product when ATCC strain 39320 was the template. 
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Figure 3.3. Anti-porter tetB gene.  The B. amyloliquefaciens-specific YyaR primer amplified a 
product with strain 39320 only (lanes 1 + 4).  No PCR amplification occurred with strain 39374 (lanes 
2 + 5).  Strain 168 (lanes 3 + 6) showed a product for B. subtilis-specific YyaO product. 
 
 
III.C. Conclusions 
 Based on the pksG sequences, 16S rRNA and rDNA SNPs, ITG region homology, 
α-amylase, thymidylate synthase, and tetB results, we have concluded that ATCC strains 
39320 and 39374 have been wrongly classified as Bacillus subtilis.  Both of these strains 
are more accurately classified as Bacillus amyloliquefaciens, and should be regarded as 
such in future research endeavors. 
III.D. Experimental 
ATCC 39320 and 39374 B. subtilis strains were obtained from the American 
Type Culture Collection (Mannassas, VA) and grown in well-aerated tryptic soy broth.  
B. subtilis 168 genomic DNA was isolated with the Wizard Genomic DNA isolation kit 
from Promega, per manufacturer’s instructions for Gram-positive bacteria.  E. coli strains 
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TOP10 and DH5α were obtained in chemically competent form from Invitrogen, Inc. and 
grown in Luria-Bertani media.  Dye-termination sequencing was performed at either 
SeqWright, Inc. (Houston, TX) or at the Institute for Health, Science, and Society (UNC 
Greensboro). 
III.D.1. PksX Presence 
Degenerate primers (Table 5) were used to amplify pksG orthologs from B. 
subtilis genomic DNA.  A PCR was performed with Taq High Fidelity polymerase as 
follows: a single 94.0 ºC hold for 2 min, followed by 30 cycles of 94.0 ºC for 30 s, 48.0 
ºC for 30 s, and 68.0 ºC for 1 min.  A 1% agarose gel showed a product for each at ~650 
bp, verifying pksG amplification.  PCR clean-up was performed on both samples, each 
cloned, transformed into E. coli TOP10 cells, and plated on LB/ampicillin plates. 
After overnight incubation at 37 ºC, 4-6 transformants were used to inoculate 
overnight starter cultures.  Following purification the next day, PCR was repeated with 
Taq Master Mix and a 45 ºC annealing temperature.  Each PCR product was run in an 1% 
agarose gel to verify the pksG insert.  A sample with an agarose gel band at ~650 bp was 
sent for DNA sequencing. 
III.D.2. rRNA and rDNA 
Primers Bsub5F, Bsub3R, 16S rDNA Up/Dn, and 16S-23S Up/Dn were used to 
amplify regions of 600 bp, 650 bp, and 400 bp respectively.  PCR was performed with 
ATCC strains 39374 and 39320 as template DNA, and Taq Master Mix polymerase.  
Reaction conditions were: an initial “hot-start” hold at 94.0 ºC for 2 min, followed by 30  
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Primer Sequence 
pksG degen Up 5’ – CTN CCN TAY GAR GAY CCC GT – 3’ 
pksG degen DN 5’ – NCK RTG NGC NCC YTT NAC CAT – 3’  
Bsub5F 5’ – AAG TCG AGC GGA CAG ATG G – 3′ 
Bsub3R 5’ – CCA GTT TCC AAT GAC CCT CCC C – 3′ 
16S rDNA Up 5’ – AAG TCG AGC GGA CAG ATG – 3’ 
16s rDNA Dn 5’ – CCA GTT TCC AAT GAC CCT CCC G – 3’ 
YyaO_F 5’ – GGA ACC AGT CCA CAG GGT TGT GG – 3’ 
YyaR_F 5’ – CGA TTG AGT GGG CRA AGG AGA ATC ATT TWT GYG GT – 3’ 
TetB_R 5’ – CCA TAT AGA GCT GTT CCA ATG GAG AGG – 3’ 
ABa3 5’ – GCA CGC TGA TGC AGT ATT TTG AAT GG – 3’ 
ABa4 5’ – GGA GCT GTC ACC TTC CCT CGT CC – 3’ 
Abs3 5’ – ACA GGA TCC TCC AGT CTT CAC ATC – 3’ 
Abs4 5’ – GTT CAT CAT TAA GGA TCC TTC CAG G – 3’ 
OTA1 5’ – ATG AGA TTC GAC AAC TCA GAG G – 3’ 
OTA2 5’ – AAA GGC AGC ATT AAA CCG C – 3’ 
16S – 23S Up 5’ – GAC TGG GGT GAA GTC GTA AC – 3’ 
16S – 23S Dn 5’ – TGG CTG GGT TGC CCC ATT CGG – 3’ 
Table 5: Primers used for taxonomy PCRs.19, 48, 53, 55  
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cycles of 94.0 ºC for 30 s, 55.0 ºC for 30 s (50.0 ºC for 16S-23S primers only), and 68.0 
ºC for 1.5 min, with a final 5 min hold at 68.0 ºC.  Amplification was verified by a 1% 
agarose gel and PCR products were purified with the QIAquick® PCR Purification Kit 
from QIAGEN Sciences.  For all purified reactions, 1 µL was subcloned into the pCR®4-
TOPO vector, spread on LB/ampicillin plates, and incubated overnight at 37 ºC.  The 
following day, individual colonies were used to inoculate starter cultures that were 
shaken overnight at 37 ºC and 225 rpm.  Once these were purified the next day, they were 
screened for the appropriate insert by a repeat PCR.  Positive transformants were sent for 
DNA sequencing. 
III.D.3. Detection of Specific Sequences 
Primers were obtained as designed by Idriss et al. for the α-amylase and thyA 
genes.  Three PCR reactions were run with for each primer set with Taq Master Mix 
polymerase, and all three Bacillus strains as genomic DNA.  A 1% agarose gel was run 
for each PCR product to determine gene presence in the various strains. 
 Using the B. amyloliquefaciens-specific ABa3/ABa4 primers, PCR conditions 
were: a 3 min hot-start at 94.0 ºC, then 30 cycles of 30 s at 94.0 ºC, 1 min at 55.0 ºC, and 
1 min at 72.0 ºC, followed by a 10 min hold at 72.0ºC.  For primers ABs3/ABs4 and 
OTA1/OTA2, specific to B. subtilis, PCR was run as follows: a 3 min hot-start at 94.0 ºC, 
30 cycles of 94.0 ºC for 30 s, 50.0 ºC for 1 min, and 72.0 ºC for 1 min, followed by a 
single, 10 min hold at 72.0 ºC.  A 1% agarose gel showed a band at ~700 bp for the thyA 
gene with B. subtilis 168, with no band for either ATCC strain.  Likewise, the ABs 
primers resulted in a band ~2 kbp for strain 168 only.  
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 Forward primers YyaO_F and YyaR_F were used in conjunction with the reverse 
primer TetB_R in the following reactions.  Thermocycler settings for these PCRs were: a 
single 94.0 ºC hold for 3 min, followed by 30 cycles of 94.0 ºC for 30 s, 52.0 ºC for 30 s, 
and 72.0 ºC for 1 min, then a single 10 min hold at 72.0 ºC.  With strain B. subtilis 168 as 
template DNA, a band was noted at ~650 bp for the YyaO_F/TetB_R reaction, and not 
for any other primer set.  With the B. amyloliquefaciens-specific YyaR_F primer, a bright 
band was noted at ~600 bp for strain 39320, but not for 39374.
CHAPTER IV 
INTRODUCTION TO FATTY ACID CATABOLISM 
 
 
IV.A. Sporulation 
 The decision to sporulate is based on a number of external and internal cellular 
signals.  Put simply, when the cell has exhausted all possibilities to acquire nutrients and 
its only option is starvation, the sporulation cycle begins.  Bacterial endospore formation 
begins with chromosomal migration to the cell poles, followed by an asymmetric cell 
division resulting in two components: the small forespore and a larger mother cell.56  
These two cells have very different roles and fates - the chromosome-heavy mother cell 
exists just long enough for the full development and protection of its smaller counterpart, 
which is destined to be the endospore.   
 The differentiation process requires both specific gene metabolism and regulation. 
Most of these processes are controlled by four different sigma factors, two per cell, that 
are activated at explicit times during sporulation.  Figure 4.1 shows a generalized 
depiction of the factors involved with different stages of division.  Initial signals from the 
bacterium lead to phosphorylation of Spo0A, the master regulator of transcription.56  
Activation of this protein and σH trigger asymmetric division and transcription of three 
Spo proteins that encode for the remaining sigma factors.
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Figure 4.1. Sigma factors involved in sporulation.56 
 
 
Immediately following cell division, the membrane-bound SpoIIE protein 
phosphatase initiates a cascade of events that result in proliferation of the σF RNA 
polymerase factor.57  Active only in the forespore, σF is responsible for initiating 
transcription of many genes that are necessary for the development and survival of 
endospore.  It also induces expression of the SpoIIR protein and another sigma factor, σG, 
which will eventually replace it in the forespore.  
  In the mother cell, the σE transcription factor is responsible for the transcription of 
more than 250 genes.58  A sampling of activities that occur via some of these genes is 
listed in Table 6.  Initially produced as an inactive, pro- σE protein, it is processed to  
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Functions of σE-Controlled Genes 
Engulfment of the forespore by the mother cell 
Inhibiting a second cell division  
Down-regulation of σG expression 
Synthesis + activation of σG and σK 
Synthesis/assembly of spore cortex 
Synthesis/assembly of spore coat 
Fatty acid oxidation 
Protein degradation 
Transport of nutrients from extracellular environment
Table 6. Examples of  σE-controlled gene functions.58 
 
 
active form by SpoIIR protein after its σF –regulated expression.56  Following conversion 
from the proprotein, σE down-regulates the genes that led to early sporulation and takes 
control of ensuing processes within the mother cell.  Once the septum between the two 
asymmetric cells is degraded, σG and σK take over as the forespore and mother cell sigma 
factors, respectively.56  
IV.B. Carbon Sources 
All organisms typically acquire the energy needed for metabolic processes by first 
breaking down glucose through the process of glycolysis.  This pathway produces the 
three-carbon molecule pyruvate, a precursor for the tricarboxylic acid (TCA) cycle.  By 
metabolizing pyruvate to acetyl-CoA, the TCA process is initiated and electrons are made 
available to the electron-transport chain, the cell’s major source of adenosine triphosphate 
(ATP).  Under conditions of low glucose concentration, cells subvert a portion of the 
TCA cycle via the glyoxylate shunt, using isocitrate lyase (ICL) and malate synthase 
enzymes to produce a malate intermediate.  This alternative pathway serves many 
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purposes: it maintains electron transfer, prevents the waste of carbon atoms through CO2 
byproducts, and maintains the availability of malate and succinate.59  These two 
intermediates are needed to preserve the concentration of oxaloacetate, whose importance 
is described later in this text. 
A second cellular response to glucose deficiency is the breakdown of fatty acids 
to provide an alternative carbon source.   These long hydrocarbon chains contain most of 
a cell’s stored energy, and the following concerted metabolic mechanism (Figure 4.2) 
leads to increased acetyl-CoA concentration. Oxidation by FAD results in a double bond 
between C2 and C3.  The second step is a stereospecific hydration reaction that results in  
 
 
Product 
   
 
Figure 4.2. The four steps of fatty acid ß-oxidation.   Oxidation of the hydrocarbon chain (1) is 
followed by hydration of the double bond (2), conversion of  hydroxyl to a keto group via a second 
oxidation step(3).  Cleavage between Cα and Cß  (4) results in either a two- or three-carbon molecule. 
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a 3-hydroxyacyl-CoA molecule.  Thirdly, a second oxidation reaction occurs, resulting in 
the conversion of a hydroxyl to keto group.  Then bond cleavage occurs between Cα and 
Cß to give the two carbon acetyl-CoA. 
However, if the fatty acid is branched or has an odd number of carbon atoms, β-
oxidation will ultimately yield a three carbon propionyl-CoA.  At high concentrations this 
compound has been implicated in cell toxicity, and so additional chemical modification is 
required.  Several pathways exist that are capable of metabolizing propionyl-CoA.  One 
of these is the methylcitric acid (MCA) cycle. After conversion of propionyl-CoA to 
pyruvate, an oxidative decarboxylation yields the required two carbon acetyl-CoA. 
IV.C. Mmg Operon 
 One particular group of σE-dependent genes was identified in 1996 by a research 
group at Emory University and dubbed the mmg operon (“mother cell metabolic 
genes”).58, 60  The six open reading frames shown (ORFs) in Figure 4.3 are capable of 
encoding genes similar to those used in fatty acid metabolism and the methylcitric acid 
cycle.60  Activated during sporulation, mmg breakdown of fatty acids is a means for 
attaining energy to drive the cell’s preparation for dormancy. 
 
 
Figure 4.3. The mmg operon. Included are five genes, the mmgO CRE region and the downstream 
yqiQ.  The sites indicated above, *1 and *2, indicate the approximate locations for primer design, 
described in Chapter 5. 
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 Each mmg gene is expected to play a different role in the β-oxidation of fatty 
acids as listed in Table 7, with the end result being pyruvate production.  Expression and  
 
MMG OPERON 
Gene Function 
mmgA Acetyl-coenzyme A (CoA) acetyltransferase [Thiolase] 
mmgB 2-Hydroxybutyryl-CoA dehydrogenase 
mmgC Acyl-CoA dehydrogenase 
mmgD Bifunctional (methyl)citrate synthase  
mmgE *2-Methylaconitate hydratase 
yqiQ Similar to methylisocitrate lyase 
Table 7. Genes of the mmg operon and their functions.  These are as described by Eichenberger et al., 
with one change.  The function for yqiQ as designated by A.L. Sonenshein is listed.58, 61   
*The function of mmgE is currently being assessed in the J.J. Reddick research lab.  
 
 
activity assessments for the first three genes have been performed by the Reddick 
research group, and work with both mmgD and mmgE are currently underway.62, 63  The 
promoter associated with this operon is dependant on σE  RNA polymerase and so, in the 
presence of glucose, the processes of sporulation and mmg gene transcription are 
suppressed.60  Also within this promoter, the Bryan group discovered a catabolite-
repressive element (CRE) responsible for regulating this suppression and termed it 
mmgO.60 
IV.D. YqiQ Protein 
The MCA metabolic pathway (Figure 4.4) is a mirror of the glyoxylate shunt; it is 
a seven-enzyme process that metabolizes propionyl-CoA to produce pyruvate via α-
oxidation.  Propionyl-CoA and oxaloacetate are joined to form 2-methylcitrate, which is 
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Figure 4.4. The methylcitrate cycle.  Propionyl-CoA is metabolized to succinate and pyruvate by 7 
enzymes: MCS (methylcitrate synthase), MCD (methylcitrate dehydrogenase), ACN (aconitase), 
MCL (methylisocitrate lyase), SDH (succinate dehydrogenase), FUM (fumarase), MQO 
(malate:quinone oxidoreductase).64 
 
 
then converted to 2-methylisocitrate to prepare for decarboxylation.  The next reaction 
results in a carbon-carbon bond cleavage, and a possible homolog of the enzyme 
responsible for this catalysis is found downstream of the mmg genes. 
At the end of the mmg operon is the yqiQ gene, which encodes an approximately 
300 amino acid sequence that Sonenshein describes as being homologous to a 
methylisocitrate lyase (MCL).61  These enzymes catalyze the reaction shown in Figure 
4.4, an aldol cleavage of 2-methylisocitrate to yield succinate and pyruvate. 
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Figure 4.5. Reaction catalyzed by methylisocitrate lyase.64 
 
 
This reaction provides pyruvate for the electron transport chain; succinate is converted 
first to fumarate and then oxaloacetate, replenishing the intermediates needed for the 
MCA cycle. 
 Though B. subtilis  responds in many ways to nutrient shortage – i.e. lipid 
degradation, inhibition of non-critical cellular processes, sporulation – it lacks a 
glyoxylate shunt.  Additionally, the methylcitrate cycle has never been demonstrated in 
the bacterium.61  Because of this, differentiating B. subtilis cells that have not entered 
sporulation typically exhibit no growth in glucose-deficient media.  
66 
 
CHAPTER V 
THE MMG OPERON OF BACILLUS SUBTILIS 
 
V.A. Goals 
 It is our hypothesis that by turning on the mmg genes, the bacterium will begin to 
utilize the MCL cycle to break down fatty acids and harness their stored energy.  These 
wild-type bacteria are unable to rely on propionate for energy.  By activating these genes 
during early culture growth, our supposition is that B. subtilis will be capable of utilizing 
propionate as the primary carbon source.  By developing a conditional knockout mutation 
of the mmg operon, the bacterium should exhibit in-vitro growth in propionate media by 
induced  MCA cycle utilization.  First, we planned to replace the mmg promoter with an 
IPTG-inducible promoter.  We would then then be able to conduct growth studies using 
media that rely on various types of carbon sources.  Our second goal was to complete the 
cloning, overexpression, and purification of the YqiQ protein. 
V.B. Results 
V.B.1. pMUTIN4 Plasmid 
 In order to develop a conditional knockout mutation of Mmg, the pMUTIN4 
cloning vector developed by Valérie Vagner et al. was used (Figure 5.1).65  Along with 
three other plasmids, this vector was constructed specifically for B. subtilis ORF 
characterization; all four are unable to replicate in the bacterium, a requirement for 
insertional mutagenesis.65  Once cloned into pMUTIN4, the mmg promoter would be
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Figure 5.1. The pMUTIN4 vector.65 
 
 
transcriptionally fused to the lacZ reporter gene and placed under control of an IPTG-
inducible Pspac promoter.  The vector contains multiple restriction endonuclease sites 
along with both an ampicillin and erythromycin resistance, enabling useful transformant 
selection. 
 Though it can not replicate in B. subtilis, a ColE1 origin site means that it can 
replicate in E. coli cells.65  By separating the mmg genes from their σE-dependant 
promoter, it should be possible to inducing their transcription via Pspac using IPTG.  This 
separation and fusion to the lacZ gene occur due to a single cross-over event (Figure 5.1.) 
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Figure 5.2. Cross-over event for pMUTIN integration.65 
 
 
V.B.2. Mmg DNA Amplification and Cloning 
 EcoRI restriction site: Two sets of PCR primers were required for the mmg 
operon in Figure 4.3; the first set was intended to amplify a region upstream of mmgA, 
including the mmgO promoter, and the second set for a sequence area just before mmgC.  
Initially, primer sets pM1 and pM2 (Table 8) were designed to amplify 210 bp and 211 
bp regions, respectively.  Using Taq Master Mix polymerase and B. subtilis 168 as 
template DNA, both pM PCR reactions were successful as determined by the agarose gel 
in Figure 5.3. 
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PCR Primers 
pM1a 5’-TAG AAG CGT CTC AAA GCT TTT GAA GC – 3’ 
pM1b 5’– GGT TTC ACC TGA ATT CCA TTC AGA AGA TAG – 3’ 
pM2a 5’– GCT GAT ATA AGC TTG GCG ACT AG – 3’ 
pM2b 5’– CGC CGA ATT CAT CGC GAA G – 3’ 
M1A 5’ – ACC GAA AGC TTC TTT CCA GAA AAG GCT TC – 3’ 
M1B 5’ – AAC TCC GGA ATT CCC GAA TTT GCC AAA TG – 3’ 
M2A 5’ – GGA TAA AGC TTC GTG TTT ATC AAT TAT GGA AG 3’
M2B 5’ – CCG CAG AAT TCG CGG GAG CAA TTT C – 3’ 
*M1B 5’ – GAG GCG GCC GCG TTT TGA AA – 3’  
*M2b 5’ – GAC GCA AAG CGG CCG CTT TA – 3’ 
G1 Forward 5’ – CAG AAG CTT TGT TTA CCG ACT TTC CA – 3’ 
G1 Reverse 5’ – GTT TGG ATC CAC ATC ATC TCC AGA GA – 3’ 
G2 Forward 5’ – CCT AAG CTT AGG CCT TGG CGA TTC – 3’ 
G2 Reverse 5’ – GAT CAG CTG GAT CCG AAA TTC GTC C – 3’ 
Table 8: Primers used for mmg PCRs.   
 
 
 
Figure 5.3. pM1 and pM2 PCR products.  Primers targeting 16S rDNA was used as a positive 
control. 
 
 
 Utilizing HindIII and EcoRI restriction sites in the primers and pMUTIN4 
plasmid, restriction digest was performed on both samples and the plasmid.  Cloning was 
attempted with each PCR product, and of 16 insert:plasmid ratios four produced colony 
growth after ligation and transformation.  For pM1, there was a single colony on plate 
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5:5; pM2 had colonies on plates 4:4, 3:6, and 6:3.  Individual colonies were placed in 
overnight, ampicillin-containing cultures.  These were purified and screened for the 
applicable inserts. 
Three screening techniques were used: first, PCR using the initial conditions for 
amplification.  Next, PCR was repeated with a lower annealing temperature of 45ºC to 
allow for nucleotide deletion that may have occurred due to primer design and restriction 
site cleavage.  Lastly, a second restriction digest was performed and the products loaded 
directly into a 1% agarose gel to verify appropriate cleavage of plasmid and inserts.  
None of these yielded any evidence of the insert, though with the third technique the 
plasmid was apparent by gel electrophoresis. 
Based on this, two more primer sets were designed.  The first, M1, amplified a 
region in close proximity to pM1, now 231 bp and still containing both the promoter 
region and mmgO.  The second, M2, consisted of a 261 bp region located just before the 
ribosomal binding region of mmgC.  As seen in Table 2, these new primers placed the 
restriction enzyme sites much closer to the 5’ end of the sequence.  Both regions were 
amplified from B. subtilis strain 168 using similar PCR parameters as before, with a new 
annealing temperature of 52ºC to account for higher TM’s of the new primers.  Agarose 
gel electrophoresis verified the amplification of each sample. 
After purification, both reactions were transfected into retransformed 
pMUTIN4/E. coli cells.  Restriction digest and ligation were performed as above, with 
one experimental change.  During both PCR and culture purification, the final product 
was obtained by using 30 µL of elution buffer EB rather than the recommended 50 µL.  
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This was done to increase the concentration of the sample.  Again, though certain 
plasmid: insert ligation reactions resulted in colony growth, none of these were positive 
for the M1 or M2 insert.   
NotI restriction site: A different restriction map of the pMUTIN4 plasmid was 
obtained from the company that provided the plasmid itself.  This map, Figure 5.1, shows 
a second EcoRI restriction site downstream of the lacZ operon.  Due to the likelihood of 
extra cutting during digestion procedures, primers M1B and M2B were re-designed to 
contain the NotI restrictrion site.  These were designated *M1B and *M2B (Table 7), and 
all cloning, digest, and ligation were repeated with these new primers.  PCRs with NotI-
containing reverse primers resulted in multiple bands on agarose gels.  Multiple attempts 
to clone PCR products into the pMUTIN4 plasmid were unsuccessful.  It was then noted 
that the designed restriction site was the complement of NotI, rather than the reverse 
complementary sequence required for successful ligation. 
BamHI restriction site: Both primer sets were redesigned to include HindIII in 
the forward primer, and BamHI in the reverse.  PCRs resulted in successful bands as 
verified by agarose gel.  A new stock of the pMUTIN4 plasmid was ordered, and PCR 
products were cloned into both the plasmid, and retransformed pMUTIN4/E. coli cells. 
A positive control reaction was performed, where the plasmid was cut with HindIII only, 
ligated and transformed into DH5α cells.  It was then determined that no ligation reaction 
was successful. 
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V.C. Conclusions and Future Work 
 Amplification of the two mmg DNA regions by PCR were accomplished using a 
variety of primer sets.  Successful reactions included the HindIII restriction sequence in a 
forward PCR primer and either EcoRI, NotI, or BamHI in the reverse.  One of two 
different pMUTIN4 maps indicates a second EcoRI restriction site that would cause 
excess cutting of the plasmid during digest, and prevent successful ligation reactions.  
While amplification was achieved using NotI, multiple bands were present for each 
reaction.  An incorrect sequence in the primer inhibited all ligation attempts. 
 Buffer incompatibility of the HindIII and BamHI restriction enzymes required a 
sequential digest protocol.  Although this was achieved, a positive control reaction 
showed that no ligation was occurring between the plasmid and inserts.  Future work will 
focus on the optimization of these reaction conditions (i.e. annealing temperature, ligase 
and buffer composition, etc.)  
V.D. Experimental 
Primer sets pM1 and pM2 were used for PCR with B. subtilis 168 under the 
following PCR conditions: a 3 minute hot start at 94ºC; 30 cycles of a 1 minute 
denaturation step at 94ºC, 1 minute annealing at 50ºC, and a 1 minute elongation at 72ºC; 
this was followed by a 10 minute hold at 72ºC, and the reactions were stored at 4ºC.  
Successful amplification was verified by 1% agarose gel electrophoresis, with each PCR 
reaction showing an appropriate band at ~200 bp.  Both products were purified with the 
QIAquick PCR Purification Kit. 
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For plasmid preparation, 1 µL of lab stock pMUTIN 4 was retransformed into 
Escherica coli DH5α cells as follows: to 100 µL of competent DH5α cells, 1 µL of 
pMUTIN 4 was added, vortexed briefly, and incubated on ice for 30 minutes.  This was 
followed by two incubations of 2 minutes at 37ºC, and 10 minutes at room temperature.  
Next, 1 mL of LB was added and the mixture incubated at 37ºC for 1.5 hours.  After a 5 
minute centrifugation at 8,000 rpm, 1 mL of supernatant was removed, cells were 
resuspended in remaining solution, and 20 µL plated on each of two LB agar plates 
containing 100 µg/mL of ampicillin.  After overnight incubation at 37ºC, both plates 
showed growth of numerous colonies.  Each subsequent time the plasmid was used for 
restriction digest procedures, a single colony was placed in an overnight culture 
containing ampicillin, and purified the next day. 
Both PCR products, along with the purified pMUTIN 4 plasmid, were digested at 
37ºC for 3.5 hours using HindIII and EcoRI restriction enzymes, and EcoRI buffer.  They 
were then deactivated at 65ºC for 20 minutes.  The plasmid digest was loaded into a 0.7% 
low-melting agarose gel and run at 120 Volts; the resulting band was excised and placed 
in a 75ºC water bath until the agarose had melted.  The two insert digests, PCR products 
pM1 and pM2, were again purified with the QIAquick® PCR Purification Kit.  Using T4 
DNA ligase, and with 16 different plasmid: insert ratios, ligation was performed 
overnight with thermocycler settings of: 30 minutes at 37ºC, 2 hours at 23ºC, and 16ºC 
for the remainder of the night.   
The following morning, all reactions were heat-deactivated for 20 minutes at 
65ºC, and transformed into DH5α as described above, using 20 µL of the ligation product 
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with 100 µL of competent DH5α cells.  The resulting mixtures were plated on LB-agar 
plates containing 100 µg/mL of ampicillin, and observed the following day for growth. 
Of the 16 insert:plasmid ratios attempted, four produced colony growth after 
ligation and transformation.  For pM1, there was a single colony on plate 5:5; pM2 had 
colonies on plates 4:4, 3:6, and 6:3.  Individual colonies were placed in overnight, 
ampicillin-containing cultures.  These were purified and screened for the applicable 
inserts.  Three screening techniques were used: PCR using the conditions described 
above, PCR with a lower annealing temperature of 45ºC, and restriction digest with the 
products loaded directly into a 1% agarose gel to verify appropriate cleavage of plasmid 
and inserts.  No insert was detected, but the plasmid was successfully cut by 
endonucleases. 
Using primer sets M1 and M2, PCRs were repeated as above, with an annealing 
temperature of 52ºC to account for higher TM’s of the new primers.  Agarose gel 
electrophoresis verified the amplification, and restriction digest, ligation and 
transformation were attempted as before.  Again, despite some colony growth following 
transformation, neither mmg insert was detected. 
A new stock of the pMUTIN4 plasmid was ordered, and primer sets G1 and G2 
were designed to contain the HindIII and BamHI restriction sites.  Using B. subtilis 168 
as the template, PCR conditions were: one 2 min hold at 94.0 ºC followed by 30 cycles of 
30 s at 94.0 ºC, 30 s at 56.0 ºC, and 1 min at 68.0 ºC, with a final 5 min hold at 68.0 ºC.  
Agarose gel electrophoresis verified amplification of ~340 bp for both reactions, and 
PCR products were purified.   
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A restriction map of the pMUTIN4 plasmid was done by incubating a 25 µL 
reaction at 37.0 ºC for 1 hour.  The mixture contained 14.0 µL of a purified plasmid 
starter culture, 7.2 µL H20, 0.3 µL BSA, 1.0 µL of HindIII or BamHI, and 2.5 µL of 
buffer 2 or BamHI buffer, respectively.  Both were run in an agarose gel, along with a 
control reaction containing no enzyme, and showed successful cutting of the plasmid by 
both enzymes in 1 hour. 
Sequential restriction digest was performed with the plasmid and G1/G2 PCR 
products.  For pMUTIN4, an initial 10 µL reaction (8.5 µL plasmid), 1.0 µL buffer 2, 0.3 
µL BSA, 0.5 µL HindIII) was incubated at 37.0 ºC for 1 hr, then heat-deactivated for 20 
min at 65.0 ºC.  Each was mixed with 33.2 µL ddH20, 5.0 µL BamHI buffer, 0.3 µL 
BSA, and 1.5 µL HindIII, and incubated at 37.0 ºC for 1 hr. 
For the G1 and G2 purified PCR products a larger reaction volume was necessary 
for increased concentration of the inserts.  The initial digest volume was 25 µL, and was 
purified with the QIAquick PCR Purification Kit following heat-deactivation.  A second 
25 µL digest reaction was performed with BamHI.  All three products were run in a 1% 
agarose gel, the bands excised and purified.   
Two ligation procedures were performed on the purified restriction digest 
products.  The Quick LigationTM Kit from New England BioLabs®, Inc. requires a 5 min 
incubation at room temperature to ligate a plasmid with a 3 molar excess of insert.  
Alternatively, multiple plasmid:insert ratios were incubated with T4 DNA ligase at 
thermocycler settings of: 30 min at 37 ºC, 2 hr at 23.0 ºC, and 16.0 ºC overnight.  The 
next day all reactions were heat-deactivated for 20 min at 65.0 ºC. 
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All ligation reactions were transformed into TOP10 cells per manufacturer’s 
instructions.  As a positive control, pMUTIN4 was digested with HindIII and ligated with 
both techniques.  G1/G2 transformation reactions were unsuccessful, and an excess of the 
positive control reaction yielded only one transformant.   
The pMUTIN4 plasmid was retransformed into E. coli DH5α cells, plated on 
LB/ampicillin plates, and incubated overnight at 37 ºC.  One colony was used to 
inoculate an overnight starter culture and the plasmid was purified the following day.  A 
single restriction digest reaction with pMUTIN4 and HindIII was repeated as a positive 
control reaction, and the product transformed into both TOP10 and competent DH5α 
cells.  Using an excess volume of the reaction again yielded only a single transformant; 
from this it was determined that the ligation step, rather than transformation, was 
unsuccessful. 
V.E. Cloning, Overexpression and Purification of the YqiQ Protein 
 A second objective of this research was to complete the cloning, overexpression, 
and purification of the YqiQ protein.  From lab stock, the BL21(DE3) plasmid containing 
the yqiQ/pET-28a plasmid (previously prepared in the Reddick laboratory by Suzette 
Mills) was streaked on an LB agar plate containing kanamycin antibiotic at a 25 µg/mL 
concentration.  One colony from the plate was grown overnight in a kanamycin-
containing culture; the following day, 2 mL of the culture was added to 1 liter LB and 
shaken at 225 rpm (37ºC) until an Absorbance of 0.5 was obtained at 595 nm.  The 
culture was then induced with 0.2382 grams of isopropyl ß-D-1-thiogalactopyranoside 
(IPTG), inactivating the lac repressor and promoting the synthesis of the YqiQ protein.  
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After shaking overnight at 225 rpm and 37ºC, the culture was centrifuged at 6,500 rpm 
for 30 minutes, supernatant decanted, and the cells stored at -80ºC. 
 Cells were resuspended in 20 mL of a binding buffer containing Tris (20 mM), 
NaCl (0.5 M), and imidizole (5 mM), at pH 7.9.  This was applied to a Ni2+ -affinity 
column, and washed with 60 mM imidizole.  Using 1 M imidizole, 1 mL elutant fractions 
were collected and a protein concentration was determined for each using the Bradford 
method.  Fractions 2 and 3 contained the highest concentration, ~2.4 and 2.0 mg/mL 
respectively, and were run on an SDS-PAGE gel to verify the YqiQ protein (Figure 4).  
Each showed a very heavy band at ~25-30 kDa, and were combined for dialysis to further 
purify the samples.  This was achieved overnight in a 25 mM Tris buffer, pH 8.0. 
The retentate was highly precipitated and so filtered the following day, leaving 
~2.5 mL of product.  The Bradford assay of this sample gave a protein concentration of 
7mg/mL, indicating that the supernatant still contained the protein.  For storage, 250 µL 
of 80% glycerol was added to give a final glycerol-weight concentration of 10%, and the 
samples stored at -80ºC.  Activity characterization will be carried out in the future by a 
member of the Reddick research group.
REFERENCES 
 
1. Seow, K. T.; Meurer, G.; Gerlitz, M.; WendtPienkowski, E.; Hutchinson, C. R.; 
Davies, J., A study of iterative type II polyketide synthases, using bacterial genes cloned 
from soil DNA: a means to access and use genes from uncultured microorganisms. 
Journal of Bacteriology 1997, 179, (23), 7360-7368. 
2. Decker, T.; Hipp, S.; Ringshausen, I.; Bogner, C.; Oelsner, M.; Schneller, F.; 
Peschel, C., Rapamycin-induced G(1) arrest in cycling B-CLL cells is associated with 
reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 2003, 101, (1), 
278-285. 
3. Schwecke, T.; Aparicio, J. F.; Molnar, I.; Konig, A.; Khaw, L. E.; Haydock, S. F.; 
Oliynyk, M.; Caffrey, P.; Cortes, J.; Lester, J. B.; Bohm, G. A.; Staunton, J.; Leadlay, P. 
F., The Biosynthetic Gene-Cluster for the Polyketide Immunosuppressant Rapamycin. 
Proceedings of the National Academy of Sciences of the United States of America 1995, 
92, (17), 7839-7843. 
4. Schupp, T.; Toupet, C.; Cluzel, B.; Neff, S.; Hill, S.; Beck, J. J.; Ligon, J. M., A 
Sorangium-Cellulosum (Myxobacterium) Gene-Cluster for the Biosynthesis of the 
Macrolide Antibiotic Soraphen a - Cloning, Characterization, and Homology to 
Polyketide Synthase Genes from Actinomycetes. Journal of Bacteriology 1995, 177, 
(13), 3673-3679. 
5. Bibb, M. J.; Biro, S.; Motamedi, H.; Collins, J. F.; Hutchinson, C. R., Analysis of 
the Nucleotide-Sequence of the Streptomyces-Glaucescens Tcml Genes Provides Key 
Information About the Enzymology of Polyketide Antibiotic Biosynthesis. Embo Journal 
1989, 8, (9), 2727-2736. 
6. Lee, S. K.; Basnet, D. B.; Choi, C. Y.; Sohng, J. K.; Ahn, J. S.; Yoon, Y. J., The 
role of erythromycin C-12 hydroxylase, EryK, as a substitute for PikC hydroxylase in 
pikromycin biosynthesis. Bioorganic Chemistry 2004, 32, (6), 549-559. 
7. Chen, X. H.; Vater, J.; Piel, J.; Franke, P.; Scholz, R.; Schneider, K.; Koumoutsi, 
A.; Hitzeroth, G.; Grammel, N.; Strittmatter, A. W.; Gottschalk, G.; Sussmuth, R. D.; 
Borriss, R., Structural and functional characterization of three polyketide synthase gene 
clusters in Bacillus amyloliquefaciens FZB 42. Journal of Bacteriology 2006, 188, (11), 
4024-4036. 
79 
 
8. Castoe, T. A.; Stephens, T.; Noonan, B. P.; Calestani, C., A novel group of type I 
polyketide synthases (PKS) in animals and the complex phylogenomics of PKSs. Gene 
2007, 392, (1-2), 47-58. 
9. Pereda, A.; Summers, R. G.; Stassi, D. L.; Ruan, X. A.; Katz, L., The loading 
domain of the erythromycin polyketide synthase is not essential for erythromycin 
biosynthesis in Saccharopolyspora erythraea. Microbiology-Sgm 1998, 144, 543-553. 
10. Jackowski, S.; Rock, C. O., Metabolism of 4'-phosphopantetheine in Escherichia 
coli. In 1984; Vol. 158, pp 115-120. 
11. Carreras, C.; Frykman, S.; Ou, S.; Cadapan, L.; Zavala, S.; Woo, E.; Leaf, T.; 
Carney, J.; Burlingame, M.; Patel, S.; Ashley, G.; Licari, P., Saccharopolyspora 
erythraea-catalyzed bioconversion of 6-deoxyerythronolide B analogs for production of 
novel erythromycins. Journal of Biotechnology 2002, 92, (3), 217-228. 
12. Mironov, V. A.; Sergienko, O. V.; Nastasyak, I. N.; Danilenko, V. N., Biogenesis 
and regulation of biosynthesis of erythromycins in Saccharopolyspora erythraea. Applied 
Biochemistry and Microbiology 2004, 40, (6), 531-541. 
13. Rawlings, B. J., Type I polyketide biosynthesis in bacteria (Part A - erythromycin 
boisynthesis). Natural Product Reports 2001, 18, (2), 190-227. 
14. Weissman, K. J.; Bycroft, M.; Staunton, J.; Leadlay, P. F., Origin of starter units 
for erythromycin biosynthesis. Biochemistry 1998, 37, (31), 11012-11017. 
15. Rawlings, B. J., Type I polyketide biosynthesis in bacteria (Part B). Natural 
Product Reports 2001, 18, (3), 231-281. 
16. Scotti, C.; Piatti, M.; Cuzzoni, A.; Perani, P.; Tognoni, A.; Grandi, G.; Galizzi, 
A.; Albertini, A. M., A Bacillus-Subtilis Large Orf Coding for a Polypeptide Highly 
Similar to Polyketide Synthases. Gene 1993, 130, (1), 65-71. 
17. Straight, P. D.; Fischbach, M. A.; Walsh, C. T.; Rudner, D. Z.; Kolter, R., A 
singular enzymatic megacomplex from Bacillus subtilis. Proceedings of the National 
Academy of Sciences of the United States of America 2007, 104, (1), 305-310. 
80 
 
18. Chang, Z. X.; Sitachitta, N.; Rossi, J. V.; Roberts, M. A.; Flatt, P. M.; Jia, J. Y.; 
Sherman, D. H.; Gerwick, W. H., Biosynthetic pathway and gene cluster analysis of 
curacin A, an antitubulin natural product from the tropical marine cyanobacterium 
Lyngbya majuscula. Journal of Natural Products 2004, 67, (8), 1356-1367. 
19. Edwards, D. J.; Marquez, B. L.; Nogle, L. M.; McPhail, K.; Goeger, D. E.; 
Roberts, M. A.; Gerwick, W. H., Structure and biosynthesis of the jamaicamides, new 
mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya 
majuscula. Chemistry & Biology 2004, 11, (6), 817-833. 
20. El-Sayed, A. K.; Hothersall, J.; Cooper, S. M.; Stephens, E.; Simpson, T. J.; 
Thomas, C. M., Characterization of the mupirocin biosynthesis gene cluster from 
Pseudomonas fluorescens NCIMB 10586. Chemistry & Biology 2003, 10, (5), 419-430. 
21. Rosenberg, E. R., Eliora; Orr, Elisha; Paitan, Yossi Antibiotic TA biosynthesis 
gene cluster of Myxococcus xanthus. 2000. 
22. Wu, J.; Hothersall, J.; Mazzetti, C.; O'Connell, Y.; Shields, J. A.; Rahman, A. S.; 
Cox, R. J.; Crosby, J.; Simpson, T. J.; Thomas, C. M.; Willis, C. L., In vivo mutational 
analysis of the mupirocin gene cluster reveals labile points in the biosynthetic pathway: 
the "Leaky Hosepipe" mechanism. Chembiochem 2008, 9, (9), 1500-1508. 
23. Calderone, C. T.; Kowtoniuk, W. E.; Kelleher, N. L.; Walsh, C. T.; Dorrestein, P. 
C., Convergence of isoprene and polyketide biosynthetic machinery: Isoprenyl-S-carrier 
proteins in the pksX pathway of Bacillus subtilis. Proceedings of the National Academy 
of Sciences of the United States of America 2006, 103, (24), 8977-8982. 
24. Butcher, R. A.; Schroeder, F. C.; Fischbach, M. A.; Straightt, P. D.; Kolter, R.; 
Walsh, C. T.; Clardy, J., The identification of bacillaene, the product of the PksX 
megacomplex in Bacillus subtilis. Proceedings of the National Academy of Sciences of 
the United States of America 2007, 104, (5), 1506-1509. 
25. Stein, T., Bacillus subtilis antibiotics: structures, syntheses and specific functions. 
Molecular Microbiology 2005, 56, (4), 845-857. 
26. Wilson, K. E.; Flor, J. E.; Schwartz, R. E.; Joshua, H.; Smith, J. L.; Pelak, B. A.; 
Liesch, J. M.; Hensens, O. D., Difficidin and Oxydifficidin - Novel Broad-Spectrum 
81 
 
Antibacterial Antibiotics Produced by Bacillus-Subtilis .2. Isolation and Physicochemical 
Characterization. Journal of Antibiotics 1987, 40, (12), 1682-1691. 
27. Zimmerman, S. B.; Schwartz, C. D.; Monaghan, R. L.; Pelak, B. A.; Weissberger, 
B.; Gilfillan, E. C.; Mochales, S.; Hernandez, S.; Currie, S. A.; Tejera, E.; Stapley, E. O., 
Difficidin and Oxydifficidin - Novel Broad-Spectrum Antibacterial Antibiotics Produced 
by Bacillus-Subtilis .1. Production, Taxonomy and Antibacterial Activity. Journal of 
Antibiotics 1987, 40, (12), 1677-1681. 
28. Zweerink, M. M.; Edison, A., Difficidin and Oxydifficidin - Novel Broad-
Spectrum Antibacterial Antibiotics Produced by Bacillus-Subtilis .3. Mode of Action of 
Difficidin. Journal of Antibiotics 1987, 40, (12), 1692-1697. 
29. Albertini, A. M.; Caramori, T.; Scoffone, F.; Scotti, C.; Galizzi, A., Sequence 
around the 159-Degrees Region of the Bacillus-Subtilis Genome - the Pksx Locus Spans 
33-Center-Dot-6 Kb. Microbiology-Uk 1995, 141, 299-309. 
30. Calderone, C. T.; Bumpus, S. B.; Kelleher, N. L.; Walsh, C. T.; Magarvey, N. A., 
A ketoreductase domain in the PksJ protein of the bacillaene assembly line carries out 
both alpha- and beta-ketone reduction during chain growth. Proceedings of the National 
Academy of Sciences of the United States of America 2008, 105, (35), 12809-12814. 
31. Kunst, F.; Ogasawara, N.; Moszer, I.; Albertini, A. M.; Alloni, G.; Azevedo, V.; 
Bertero, M. G.; Bessieres, P.; Bolotin, A.; Borchert, S.; Borriss, R.; Boursier, L.; Brans, 
A.; Braun, M.; Brignell, S. C.; Bron, S.; Brouillet, S.; Bruschi, C. V.; Caldwell, B.; 
Capuano, V.; Carter, N. M.; Choi, S. K.; Codani, J. J.; Connerton, I. F.; Cummings, N. J.; 
Daniel, R. A.; Denizot, F.; Devine, K. M.; Dusterhoft, A.; Ehrlich, S. D.; Emmerson, P. 
T.; Entian, K. D.; Errington, J.; Fabret, C.; Ferrari, E.; Foulger, D.; Fritz, C.; Fujita, M.; 
Fujita, Y.; Fuma, S.; Galizzi, A.; Galleron, N.; Ghim, S. Y.; Glaser, P.; Goffeau, A.; 
Golightly, E. J.; Grandi, G.; Guiseppi, G.; Guy, B. J.; Haga, K.; Haiech, J.; Harwood, C. 
R.; Henaut, A.; Hilbert, H.; Holsappel, S.; Hosono, S.; Hullo, M. F.; Itaya, M.; Jones, L.; 
Joris, B.; Karamata, D.; Kasahara, Y.; KlaerrBlanchard, M.; Klein, C.; Kobayashi, Y.; 
Koetter, P.; Koningstein, G.; Krogh, S.; Kumano, M.; Kurita, K.; Lapidus, A.; Lardinois, 
S.; Lauber, J.; Lazarevic, V.; Lee, S. M.; Levine, A.; Liu, H.; Masuda, S.; Mauel, C.; 
Medigue, C.; Medina, N.; Mellado, R. P.; Mizuno, M.; Moestl, D.; Nakai, S.; Noback, 
M.; Noone, D.; Oreilly, M.; Ogawa, K.; Ogiwara, A.; Oudega, B.; Park, S. H.; Parro, V.; 
Pohl, T. M.; Portetelle, D.; Porwollik, S.; Prescott, A. M.; Presecan, E.; Pujic, P.; 
Purnelle, B.; Rapoport, G.; Rey, M.; Reynolds, S.; Rieger, M.; Rivolta, C.; Rocha, E.; 
Roche, B.; Rose, M.; Sadaie, Y.; Sato, T.; Scanlan, E.; Schleich, S.; Schroeter, R.; 
Scoffone, F.; Sekiguchi, J.; Sekowska, A.; Seror, S. J.; Serror, P.; Shin, B. S.; Soldo, B.; 
82 
 
Sorokin, A.; Tacconi, E.; Takagi, T.; Takahashi, H.; Takemaru, K.; Takeuchi, M.; 
Tamakoshi, A.; Tanaka, T.; Terpstra, P.; Tognoni, A.; Tosato, V.; Uchiyama, S.; 
Vandenbol, M.; Vannier, F.; Vassarotti, A.; Viari, A.; Wambutt, R.; Wedler, E.; Wedler, 
H.; Weitzenegger, T.; Winters, P.; Wipat, A.; Yamamoto, H.; Yamane, K.; Yasumoto, 
K.; Yata, K.; Yoshida, K.; Yoshikawa, H. F.; Zumstein, E.; Yoshikawa, H.; Danchin, A., 
The complete genome sequence of the Gram-positive bacterium Bacillus subtilis. Nature 
1997, 390, (6657), 249-256. 
32. Zimmerman, S. B. S., NJ), Wilson, Kenneth E. (Westfield, NJ), Monaghan, 
Richard L. (Somerset, NJ), Del Val, Sagrario M. (Madrid, ES), Fernandez I, Maria M. 
(Madrid, ES), Hensens, Otto D. (Red Bank, NJ), Flor, James E. (Bridgewater, NJ), 
Deriso, Cheryl (Avenel, NJ) Difficidin and derivative antibacterials. 1985. 
33. Mootz, H. D.; Finking, R.; Marahiel, M. A., 4 '-phosphopantetheine transfer in 
primary and secondary metabolism of Bacillus subtilis. Journal of Biological Chemistry 
2001, 276, (40), 37289-37298. 
34. Nakano, M. M.; Corbell, N.; Besson, J.; Zuber, P., Isolation and Characterization 
of Sfp - a Gene That Functions in the Production of the Lipopeptide Biosurfactant, 
Surfactin, in Bacillus-Subtilis. Molecular & General Genetics 1992, 232, (2), 313-321. 
35. Quadri, L. E. N.; Weinreb, P. H.; Lei, M.; Nakano, M. M.; Zuber, P.; Walsh, C. 
T., Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for 
peptidyl carrier protein domains in peptide synthetases. Biochemistry 1998, 37, (6), 1585-
1595. 
36. Tsuge, K.; Ano, T.; Shoda, M., Isolation of a gene essential for biosynthesis of the 
lipopeptide antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8. Archives of 
Microbiology 1996, 165, (4), 243-251. 
37. Moldenhauer, J.; Chen, X. H.; Borriss, R.; Piel, J., Biosynthesis of the antibiotic 
bacillaene, the product of a giant polyketide synthase complex of the trans-AT family. 
Angewandte Chemie-International Edition 2007, 46, (43), 8195-8197. 
38. Wawrik, B.; Kerkhof, L.; Zylstra, G. J.; Kukor, J. J., Identification of unique type 
II polyketide synthase genes in soil. Applied and Environmental Microbiology 2005, 71, 
(5), 2232-2238. 
83 
 
39. Miller, D. N.; Bryant, J. E.; Madsen, E. L.; Ghiorse, W. C., Evaluation and 
optimization of DNA extraction and purification procedures for soil and sediment 
samples. Applied and Environmental Microbiology 1999, 65, (11), 4715-4724. 
40. Zhou, J. Z.; Bruns, M. A.; Tiedje, J. M., DNA recovery from soils of diverse 
composition. Applied and Environmental Microbiology 1996, 62, (2), 316-322. 
41. Brady, S. F., Construction of soil environmental DNA cosmid libraries and 
screening for clones that produce biologically active small molecules. Nature Protocols 
2007, 2, (5), 1297-1305. 
42. Spear, J. R.; Ley, R. E.; Berger, A. B.; Pace, N. R. In Complexity in natural 
microbial ecosystems: The Guerrero Negro experience, 2003; 2003; pp 168-173. 
43. Bumpus, S. B.; Magarvey, N. A.; Kelleher, N. L.; Walsh, C. T.; Calderone, C. T., 
Polyunsaturated Fatty-Acid-Like Trans-Enoyl Reductases Utilized in Polyketide 
Biosynthesis. Journal of the American Chemical Society 2008, 130, (35), 11614-11616. 
44. Euzeby, J. P., Bacterial Nomenclature - Changes of Veterinary Interest During 
1993. Revue De Medecine Veterinaire 1994, 145, (1), 3-31. 
45. Metsa-Ketela, M.; Halo, L.; Munukka, E.; Hakala, J.; Mantsala, P.; Ylihonko, K., 
Molecular evolution of aromatic polyketides and comparative sequence analysis of 
polyketide ketosynthase and 16S ribosomal DNA genes from various streptomyces 
species. Applied and Environmental Microbiology 2002, 68, (9), 4472-4479. 
46. Metsa-Ketela, M.; Salo, V.; Halo, L.; Hautala, A.; Hakala, J.; Mantsala, P.; 
Ylihonko, K., An efficient approach for screening minimal PKS genes from 
Streptomyces. Fems Microbiology Letters 1999, 180, (1), 1-6. 
47. Ash, C.; Farrow, J. A. E.; Wallbanks, S.; Collins, M. D., Phylogenetic 
Heterogeneity of the Genus Bacillus Revealed by Comparative-Analysis of Small-
Subunit-Ribosomal Rna Sequences. Letters in Applied Microbiology 1991, 13, (4), 202-
206. 
48. Wattiau, P.; Renard, M. E.; Ledent, P.; Debois, V.; Blackman, G.; Agathos, S. N., 
A PCR test to identify Bacillus subtilis and closely related species and its application to 
84 
 
the monitoring of wastewater biotreatment. Applied Microbiology and Biotechnology 
2001, 56, (5-6), 816-819. 
49. Daffonchio, D.; Cherif, A.; Brusetti, L.; Rizzi, A.; Mora, D.; Boudabous, A.; 
Borin, S., Nature of Polymorphisms in 16S-23S rRNA Gene Intergenic Transcribed 
Spacer Fingerprinting of Bacillus and Related Genera. In 2003; Vol. 69, pp 5128-5137. 
50. Daffonchio, D.; Borin, S.; Consolandi, A.; Mora, D.; Manachini, P. L.; Sorlini, C., 
16S-23S rRNA internal transcribed spacers as molecular markers for the species of the 
16S rRNA group I of the genus Bacillus. FEMS Microbiology Letters 1998, 163, (2), 
229-236. 
51. Ni, Y. Q.; Wan, D. S.; He, K. Y., 6S rDNA and 16S-23S internal transcribed 
spacer sequence analyses reveal inter- and intraspecific Acidithibacillus phylogeny. 
Microbiology-Sgm 2008, 154, 2397-2407. 
52. Sagredo, B.; Jedlicki, E.; Orellana, O. In Organization of the 16s-23s Intergenic 
Spacer Region of the 2 Rna Operons from Thiobacillus-Ferrooxidans, 1992; 1992; pp 
239-247. 
53. Idriss, E. E.; Makarewicz, O.; Farouk, A.; Rosner, K.; Greiner, R.; Bochow, H.; 
Richter, T.; Borriss, R., Extracellular phytase activity of Bacillus amyloliquefaciens 
FZB45 contributes to its plant-growth-promoting effect. Microbiology-Sgm 2002, 148, 
2097-2109. 
54. Reva, O. N.; Dixelius, C.; Meijer, J.; Priest, F. G., Taxonomic characterization 
and plant colonizing abilities of some bacteria related to Bacillus amyloliquefaciens and 
Bacillus subtilis. Fems Microbiology Ecology 2004, 48, (2), 249-259. 
55. Lampel, K. A.; Dyer, D.; Kornegay, L.; Orlandi, P. A., Detection of Bacillus 
spores using PCR and FTA filters. Journal of Food Protection 2004, 67, (5), 1036-1038. 
56. Piggot, P. J.; Hilbert, D. W., Sporulation of Bacillus subtilis. Current Opinion in 
Microbiology 2004, 7, (6), 579-586. 
85 
 
86 
 
57. Hilbert, D. W.; Piggot, P. J., Novel spoIIE mutation that causes 
uncompartmentalized sigma(F) activation in Bacillus subtilis. Journal of Bacteriology 
2003, 185, (5), 1590-1598. 
58. Eichenberger, P.; Jensen, S. T.; Conlon, E. M.; van Ooij, C.; Silvaggi, J.; 
Gonzalez-Pastor, J. E.; Fujita, M.; Ben-Yehuda, S.; Stragier, P.; Liu, J. S.; Losick, R., 
The sigma(Epsilon) regulon and the identification of additional sporulation genes in 
Bacillus subtilis. Journal of Molecular Biology 2003, 327, (5), 945-972. 
59. Gould, T. A.; de Langemheen, H. V.; Munoz-Elias, E. J.; McKinney, J. D.; 
Sacchettini, J. C., Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles 
in Mycobacterium tuberculosis. Molecular Microbiology 2006, 61, (4), 940-947. 
60. Bryan, E. M.; Beall, B. W.; Moran, C. P., A sigma(E)-dependent operon subject 
to catabolite repression during sporulation in Bacillus subtilis. Journal of Bacteriology 
1996, 178, (16), 4778-4786. 
61. Sonenshein, A. L., The Krebs Citric Acid Cycle. In Bacillus subtilis and Its 
Closes Relatives: from Genes to Cells, A. L. Sonenshein, e. A., Ed. ASM Press: 
Washington, D.C., 2002; pp 151-162. 
62. Reddick, J. J.; Antolak, S. A.; Raner, G. M., PksS from Bacillus subtilis is a 
cytochrome P450 involved in bacillaene metabolism. Biochemical and Biophysical 
Research Communications 2007, 358, (1), 363-367. 
63. Reddick, J. J.; Williams, J. K., The mmgA gene from Bacillus subtilis encodes a 
degradative acetoacetyl-CoA thiolase. Biotechnology Letters 2008, 30, (6), 1045-1050. 
64. Upton, A. M.; McKinney, J. D., Role of the methylcitrate cycle in propionate 
metabolism and detoxification in Mycobacterium smegmatis. Microbiology-Sgm 2007, 
153, 3973-3982. 
65. Vagner, V.; Dervyn, E.; Ehrlich, S. D., A vector for systematic gene inactivation 
in Bacillus subtilis. Microbiology-Sgm 1998, 144, 3097-3104. 
 
 
